Testing of Bisphenol A, 44535-44547 [2011-18842]
Download as PDF
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
rulemaking. EPA has considered these
requests and has decided to reopen the
comment period for an additional 15
days from the date of publication of
today’s rulemaking.
This reopening is for the limited
purpose of public review and comment
on the potential impacts of the final
CSAPR on EPA’s proposed rulemaking
to approve Tennessee’s Regional Haze
SIP. EPA does not anticipate any
impacts from the CSAPR on the
proposed rulemaking on the Tennessee
Regional Haze SIP. As noted in the
CSAPR, EPA has not conducted any
technical analysis to determine whether
compliance with the CSAPR would
satisfy Regional Haze Best Available
Retrofit Technology (BART)-related
requirements for electric generating
units (EGUs). For that reason, EPA has
neither made any determinations nor
established any presumptions that
compliance with the CSAPR satisfies
BART-related requirements for EGUs.
EPA intends to undertake a separate
analysis to determine if compliance
with the CSAPR would provide
sufficient reductions to satisfy BART
requirements for EGUs in accordance
with Regional Haze Rule requirements
for alternative BART compliance
options as soon as practicable following
official promulgation of the CSAPR.
Dated: July 15, 2011.
Gwendolyn Keyes Fleming,
Regional Administrator, Region 4.
[FR Doc. 2011–18833 Filed 7–25–11; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 52
[EPA–R09–OAR–2011–0042; FRL–9279–4]
Revisions to the California State
Implementation Plan, Northern Sierra
Air Quality Management District,
Sacramento Metropolitan Air Quality
Management District, and South Coast
Air Quality Management District
Environmental Protection
Agency (EPA).
ACTION: Proposed rule.
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
AGENCY:
EPA is proposing to approve
revisions to the Northern Sierra Air
Quality Management District
(NSAQMD), Sacramento Metropolitan
Air Quality Management District
(SMAQMD), and South Coast Air
Quality Management District
(SCAQMD) portions of the California
State Implementation Plan (SIP). These
revisions concern volatile organic
SUMMARY:
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
compound (VOC) emissions from
gasoline dispensing facilities, polyester
resin operations, and spray booth
facilities. We are proposing to approve
local rules to regulate these emission
sources under the Clean Air Act as
amended in 1990 (CAA or the Act).
DATES: Any comments on this proposal
must arrive by August 25, 2011.
ADDRESSES: Submit comments,
identified by docket number EPA–R09–
OAR–2011–0042, by one of the
following methods:
1. Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions.
2. E-mail: steckel.andrew@epa.gov.
3. Mail or deliver: Andrew Steckel
(Air-4), U.S. Environmental Protection
Agency Region IX, 75 Hawthorne Street,
San Francisco, CA 94105–3901.
Instructions: All comments will be
included in the public docket without
change and may be made available
online at https://www.regulations.gov,
including any personal information
provided, unless the comment includes
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. Information that
you consider CBI or otherwise protected
should be clearly identified as such and
should not be submitted through https://
www.regulations.gov or e-mail. https://
www.regulations.gov is an ‘‘anonymous
access’’ system, and EPA will not know
your identity or contact information
unless you provide it in the body of
your comment. If you send e-mail
directly to EPA, your e-mail address
will be automatically captured and
included as part of the public comment.
If EPA cannot read your comment due
to technical difficulties and cannot
contact you for clarification, EPA may
not be able to consider your comment.
Electronic files should avoid the use of
special characters, any form of
encryption, and be free of any defects or
viruses.
Docket: The index to the docket for
this action is available electronically at
https://www.regulations.gov and in hard
copy at EPA Region IX, 75 Hawthorne
Street, San Francisco, California. While
all documents in the docket are listed in
the index, some information may be
publicly available only at the hard copy
location (e.g., copyrighted material), and
some may not be publicly available in
either location (e.g., CBI). To inspect the
hard copy materials, please schedule an
appointment during normal business
hours with the contact listed in the FOR
FURTHER INFORMATION CONTACT section.
FOR FURTHER INFORMATION CONTACT:
David Grounds, EPA Region IX, (415)
972–3019, grounds.david@epa.gov.
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
44535
This
proposal addresses the following local
rules: NSAQMD Rule 215, SMAQMD
Rule 465, and SCAQMD Rules 1132 and
1162. In the Rules and Regulations
section of this Federal Register, we are
approving these local rules in a direct
final action without prior proposal
because we believe these SIP revisions
are not controversial. If we receive
adverse comments, however, we will
publish a timely withdrawal of the
direct final rule and address the
comments in subsequent action based
on this proposed rule. Please note that
if we receive adverse comment on an
amendment, paragraph, or section of
this rule and if that provision may be
severed from the remainder of the rule,
we may adopt as final those provisions
of the rule that are not the subject of an
adverse comment.
We do not plan to open a second
comment period, so anyone interested
in commenting should do so at this
time. If we do not receive adverse
comments, no further activity is
planned. For further information, please
see the direct final action.
SUPPLEMENTARY INFORMATION:
Dated: February 15, 2011.
Jared Blumenfeld,
Regional Administrator, Region IX.
[FR Doc. 2011–18871 Filed 7–25–11; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 799
[EPA–HQ–OPPT–2010–0812; FRL–8880–3]
RIN 2070–AJ83
Testing of Bisphenol A
Environmental Protection
Agency (EPA).
ACTION: Advance notice of proposed
rulemaking (ANPRM).
AGENCY:
Bisphenol A (BPA) (Chemical
Abstracts Service Registry Number
(CASRN) 80–05–7), a high production
volume (HPV) chemical, is a
reproductive, developmental, and
systemic toxicant in animal studies and
is weakly estrogenic. EPA is providing
this ANPRM to request comment on
requiring toxicity testing to determine
the potential for BPA to cause adverse
effects, including endocrine-related
effects, in environmental organisms at
low concentrations. EPA is also seeking
comment on requiring environmental
testing consisting of sampling and
monitoring for BPA in surface water,
ground water, drinking water, soil,
sediment, sludge, and landfill leachate
SUMMARY:
E:\FR\FM\26JYP1.SGM
26JYP1
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
44536
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
in the vicinity of expected BPA releases
to determine whether environmental
organisms may currently be exposed to
concentrations of BPA in the
environment that are at or above levels
of concern for adverse effects, including
endocrine-related effects. This ANPRM
is directed only toward the
environmental presence and
environmental effects of BPA. EPA is
working with the Department of Health
and Human Services (HHS) on potential
human health issues, but is not
considering any additional testing
specifically in regard to human health
issues at this time.
DATES: Comments must be received on
or before September 26, 2011.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPPT–2010–0812, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Document Control Office
(7407M), Office of Pollution Prevention
and Toxics (OPPT), Environmental
Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460–
0001.
• Hand Delivery: OPPT Document
Control Office (DCO), EPA East Bldg.,
Rm. 6428, 1201 Constitution Ave., NW.,
Washington, DC. Attention: Docket ID
Number EPA–HQ–OPPT–2010–0812.
The DCO is open from 8 a.m. to 4 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
DCO is (202) 564–8930. Such deliveries
are only accepted during the DCO’s
normal hours of operation, and special
arrangements should be made for
deliveries of boxed information.
Instructions: Direct your comments to
docket ID number EPA–HQ–OPPT–
2010–0812. EPA’s policy is that all
comments received will be included in
the docket without change and may be
made available on-line at https://
www.regulations.gov, including any
personal information provided, unless
the comment includes information
claimed to be Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Do not submit information that you
consider to be CBI or otherwise
protected through regulations.gov or email. The regulations.gov Web site is an
‘‘anonymous access’’ system, which
means EPA will not know your identity
or contact information unless you
provide it in the body of your comment.
If you send an e-mail comment directly
to EPA without going through
regulations.gov, your e-mail address
will be automatically captured and
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
included as part of the comment that is
placed in the docket and made available
on the Internet. If you submit an
electronic comment, EPA recommends
that you include your name and other
contact information in the body of your
comment and with any disk or CD-ROM
you submit. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment. Electronic files should avoid
the use of special characters, any form
of encryption, and be free of any defects
or viruses.
Docket: All documents in the docket
are listed in the docket index available
at https://www.regulations.gov. Although
listed in the index, some information is
not publicly available, e.g., CBI or other
information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
will be publicly available only in hard
copy. Publicly available docket
materials are available electronically at
https://www.regulations.gov, or, if only
available in hard copy, at the OPPT
Docket. The OPPT Docket is located in
the EPA Docket Center (EPA/DC) at Rm.
3334, EPA West Bldg., 1301
Constitution Ave., NW., Washington,
DC. The EPA/DC Public Reading Room
hours of operation are 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding
legal holidays. The telephone number of
the EPA/DC Public Reading Room is
(202) 566–1744, and the telephone
number for the OPPT Docket is (202)
566–0280. Docket visitors are required
to show photographic identification,
pass through a metal detector, and sign
the EPA visitor log. All visitor bags are
processed through an X-ray machine
and subject to search. Visitors will be
provided an EPA/DC badge that must be
visible at all times in the building and
returned upon departure.
For
technical information contact: Mary
Dominiak, Chemical Control Division
(7405M), Office of Pollution Prevention
and Toxics, Environmental Protection
Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460–0001; telephone
number: (202) 564–8104; e-mail address:
dominiak.mary@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; e-mail address: TSCAHotline@epa.gov.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you manufacture (defined
by statute to include import) or process
BPA (CASRN 80–05–7). BPA is listed on
the Toxic Substances Control Act
(TSCA) Chemical Substance Inventory
(TSCA Inventory) under the name
phenol, 4,4’-(1-methylethylidene)bis-.
Potentially affected entities may
include, but are not limited to:
• Chemical manufacturers (including
importers) (NAICS codes 325, 32411),
e.g., chemical manufacturing and
petroleum refineries of BPA.
• Plastics material and resin
manufacturers (NAICS code 325211),
e.g., manufacturers and processors of
BPA-based polycarbonate plastics and
epoxy resins.
• Foundries (NAICS codes 331512,
331524, 331528), e.g., steel investment
foundries, aluminum foundries, and
other non-ferrous foundries, except diecasting, using BPA in casting sands.
• Paint and coating manufacturers
(NAICS code 325510), e.g.,
manufacturers of epoxy-based paints
and other coating products that may
contain BPA.
• Paper recyclers (NAICS codes
322110, 322121, 3222), e.g., pulp mills,
paper (except newsprint) mills, and
converted paper product manufacturers
that may process waste thermal paper
containing BPA.
• Materials recovery facilities (NAICS
code 562920), e.g., facilities separating
and sorting recyclable materials that
may handle thermal paper,
polycarbonates, or food and beverage
cans lined with BPA-based epoxy
coatings.
• Custom compounders of purchased
resins (NAICS code 325991), e.g.,
facilities where resins are made from
recycled polycarbonate plastics that
may contain BPA.
This listing is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the technical person listed under FOR
FURTHER INFORMATION CONTACT.
E:\FR\FM\26JYP1.SGM
26JYP1
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
regulations.gov or e-mail. Clearly mark
the part or all of the information that
you claim to be CBI. For CBI
information in a disk or CD-ROM that
you mail to EPA, mark the outside of the
disk or CD-ROM as CBI and then
identify electronically within the disk or
CD-ROM the specific information that is
claimed as CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When submitting comments, remember
to:
i. Identify the document by docket ID
number and other identifying
information (subject heading, Federal
Register date and page number).
ii. Follow directions. The Agency may
ask you to respond to specific questions
or organize comments by referencing a
Code of Federal Regulations (CFR) part
or section number.
iii. Explain why you agree or disagree;
suggest alternatives and substitute
language for your requested changes.
iv. Describe any assumptions and
provide any technical information and/
or data that you used.
v. If you estimate potential costs or
burdens, explain how you arrived at
your estimate in sufficient detail to
allow for it to be reproduced.
vi. Provide specific examples to
illustrate your concerns and suggest
alternatives.
vii. Explain your views as clearly as
possible, avoiding the use of profanity
or personal threats.
viii. Make sure to submit your
comments by the comment period
deadline identified.
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
II. Background
A. What action is the agency taking?
As a follow-up to the BPA Action
Plan released on March 29, 2010 (Ref.
1), EPA is issuing this ANPRM under
TSCA section 4(a) (15 U.S.C. 2603(a)) to
solicit public input on the necessity for
and best approach to obtain
environmental effects, exposure, and
pathway information relevant to a
determination that BPA either does or
does not present an unreasonable risk of
injury to the environment. In particular,
EPA requests comment on:
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
1. Whether EPA should propose
requiring specific toxicity testing to
more fully characterize the effects of
BPA on environmental organisms at low
concentrations.
2. Whether EPA should propose
requiring environmental testing
consisting of sampling and monitoring,
particularly in the vicinity of reported
releases of BPA into the environment,
and what design and protocol it should
use for such sampling and monitoring,
in order to identify potential sources
and pathways of exposure and
determine the extent to which
environmental organisms may be
exposed to BPA concentrations of
concern as determined by existing data
and by additional studies that are either
already underway or would be
conducted under a test rule.
3. EPA additionally requests comment
and supporting information regarding
which TSCA section 4(a)(1) finding
authority would be most appropriate for
the purpose of a BPA test rule proposal,
as discussed in Unit II.C. Any proposal
would ultimately be based on EPA’s
assessment of the relevant information
available at the time of proposal.
B. What testing is EPA considering in
this ANPRM?
In this ANPRM, EPA is considering
requiring both toxicity testing for
environmental organisms exposed to
BPA and environmental testing
consisting of sampling and monitoring
in the vicinity of reported BPA releases
to measure its environmental presence.
The toxicity testing is being considered
to resolve existing uncertainties
concerning the potential for BPA to
elicit adverse effects in ecologically
relevant species, including endocrinerelated impacts that could occur at low
doses. The environmental testing is
being considered to resolve existing
uncertainties concerning potential
sources of and pathways leading to
environmental exposures and to
determine whether or not the
concentrations to which organisms
currently may be exposed in the
environment are at or above levels of
concern for adverse effects, including
endocrine-related effects.
On May 17, 1985, EPA published in
the Federal Register a proposed rule (50
FR 20691) to require human health and
environmental testing in response to the
TSCA Interagency Testing Committee’s
(ITC) 14th report published in the
Federal Register issue of May 29, 1984
(49 FR 22389), which designated BPA
for priority consideration for health and
environmental effects. EPA proposed
standard freshwater and marine acute
fish and aquatic invertebrate toxicity
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
44537
tests, and freshwater aquatic plant
toxicity tests. Test results were
submitted in response to the proposal
for freshwater and marine acute fish,
acute aquatic invertebrate, and algal
toxicity. EPA’s final rule published in
the Federal Register issue of September
18, 1986 (51 FR 33047) (1986 Final
Rule), terminated the test rule process
for environmental effects testing for
BPA. At the time, EPA determined that
the test data were adequate and that
chronic freshwater organism testing was
not needed because the LC50 values for
the standard acute aquatic organism
toxicity tests were greater than 1.0 parts
per million (ppm) (1 milligram/Liter
(mg/L)), and the ratios of 48-hour to 96hour LC50 values were not greater than
2. Since the 1986 Final Rule, however,
several studies on BPA have raised
concerns about its environmental effects
at concentrations less than 1.0 ppm (1
mg/L).
As stated in the BPA Action Plan (Ref.
1), EPA does not intend to initiate
regulatory action under TSCA at this
time on the basis of human health. EPA
remains committed to protecting human
health, but notes that most human
exposure, including exposure to
children, comes through food packaging
materials under the jurisdiction of the
Food and Drug Administration (FDA) in
HHS. FDA, together with the Centers for
Disease Control and Prevention (CDC)
and the National Institute of
Environmental Health Sciences
(NIEHS), is investing in important new
health studies in both animals and
humans to better determine and
evaluate the potential health
consequences of BPA exposures. EPA
will continue to coordinate closely with
FDA, CDC, and NIEHS on this activity.
To the extent that FDA may identify
health concerns from BPA in food
contact materials, EPA will work with
FDA to identify and assess potential
substitutes. Levels of exposure that may
be identified by the ongoing review as
being of concern to human health,
including children’s health, will affect
the extent to which EPA would take
additional action to address potential
risks to human health resulting from
uses within TSCA jurisdiction.
1. What is currently known about the
environmental hazard of BPA? The
toxicity of BPA has been studied
extensively, as indicated in the multiple
studies cited in the BPA Action Plan
(Ref. 1).1 There is general agreement
1 EPA’s response to the request for correction of
the information provided in the Action Plan that
was filed under the ‘‘Agency’s Information Quality
Guidelines’’ by the American Chemistry Council is
E:\FR\FM\26JYP1.SGM
Continued
26JYP1
44538
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
among multiple reviewers, including
government regulatory agencies in the
United States, Japan, the European
Union (EU), and Canada, that BPA is a
reproductive and developmental
toxicant at doses in animal studies of ≥
50 mg/kilogram-body weight (kg-bw)/
day (delayed puberty in male and
female rats and male mice; discussed in
Refs. 2–9); ≥ 235 mg/kg-bw/day
(reduced fetal or birth weight or growth
early in life, effects on testis of male
rats; Ref. 9); and ≥ 500 mg/kg-bw/day
(possible decreased fertility in mice,
altered estrous cycling in female rats,
and reduced survival of fetuses; Ref. 9).
Systemic effects (reduction in body
weight, changes in relative organ
weights, and increases in liver toxicity;
Refs. 2–8) were observed at doses above
5 mg/kg-bw/day (identified as a no
observed adverse effect level (NOAEL);
lowest observed adverse effect level
(LOAEL) of 50 mg/kg-bw/day). There
are reports of endocrine-related lowdose effects on puberty and neurological
development (brain, behavior; Ref. 9) at
doses in animal studies as low as 2
microgram (μg)/kg-bw/day. There is
disagreement in the scientific
community at large about whether
effects seen at doses in animals less than
1 mg/kg/day are meaningful and
relevant to humans. FDA, together with
NIEHS and CDC, are engaging in
additional research to better determine
and evaluate the potential human health
consequences of exposures to BPA,
including exposures at low doses (Ref.
10). EPA is working with FDA, NIEHS,
and CDC on this ongoing research, and
is not considering any additional testing
specifically in regard to human health
issues at this time.
Many studies have been conducted to
determine potential effects of BPA
exposure on invertebrates, fish,
amphibians, reptiles, birds, and wild
mammals, and a review is provided by
Crain et al. (Ref. 11). In general, studies
have shown that BPA can affect growth,
reproduction, and development in
aquatic organisms. Evidence of sublethal effects mediated through either
endocrine or non-endocrine related
mechanisms in fish, amphibians,
reptiles, and invertebrate aquatic
organisms has been reported at
potentially environmentally relevant
exposure levels lower than those
required for acute toxicity. There is a
widespread variation in reported values
for these sub-lethal effects, but many fall
in the range of 1 μg/L to 1 mg/L (Ref.
6; also, see individual studies noted in
Table 2 of Unit II.B.2.).
The ecological hazard for BPA has
been evaluated in three different risk
assessments performed by the EU,
Canada, and Japan (Refs. 7, 6, and 8), as
summarized in Table 1 of this unit. The
different methodologies, endpoints, and
study results used by each country to
derive their ecological values highlight
the significant uncertainty in the
estimated hazard values. Japan
concluded that ‘‘the current exposure
levels of BPA will not pose
unacceptable risks to the local
populations of aquatic life, particularly
fish’’ (Ref. 8). In contrast, the EU
concluded that although the predicted
exposure concentrations were
significantly below its hazard values,
there was a need for further information
and/or testing on such organisms as
freshwater snails (Ref. 7).
Canada used a study (Ref. 12) that
reported reduced sperm quality and
delayed ovulation in brown trout at a
very low concentration in water (1.75
μg/L). Other effects such as the
induction of intersex (or testes-ova in
males and females), decreased
spermatogenesis, induction of
vitellogenin, delayed or ceased
ovulation, or histological liver changes
were also reported in other studies
referenced in the EU and Japanese
hazard evaluations. However, because
there were no standardized test
guidelines or risk assessment guidance
for evaluating some of these endocrinerelated effects at the time of these
assessments, the EU and Japan set
ecotoxicological hazard values based on
conventional effects (mortality and
reproductive effects) from standardized
studies. In contrast, Canada concluded
in its hazard characterization that:
[c]onsidered together, the data provide
strong evidence that bisphenol A is capable
of eliciting adverse effects: (1) following
prolonged exposure at levels below those
usually seen to elicit effects in standard
toxicity tests (i.e., tests based on recognized
methods which evaluate endpoints such as
survival, reproduction and growth); (2)
following brief low-dose exposure,
particularly at sensitive developmental
stages, with effects apparent later in the life
cycle; (3) on filial generations following
parental exposure; and (4) using more than
one mode of action.
(Ref. 6)
Canada concluded that BPA
concentrations in water have the
potential to cause adverse effects on
populations of pelagic organisms in
Canada and concentrations in biota have
the potential to cause adverse effects in
populations of wildlife in Canada, but
that there is a low risk of direct adverse
effects to sediment organisms and to
avian wildlife species in Canada. In the
conclusion of its risk assessment,
Canada stated that it is considered
appropriate to apply a precautionary
approach when characterizing risk,
observing ‘‘it is concluded that
bisphenol A is entering the environment
in a quantity or concentration or under
conditions that have or may have an
immediate or long-term harmful effect
on the environment or its biological
diversity’’ (Ref. 6).
TABLE 1—SUMMARY OF BISPHENOL A ECOLOGICAL VALUES
Country
Predicted no effect
concentrations
(microgram/Liter
(μg/L)) 1
Endpoints
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
European Union ....................
1.5
Canada ..................................
0.175
The predicted no effect concentration (PNEC) for aquatic organisms (derived by using a
statistical analysis of data from available data on freshwater and marine aquatic organisms (in this case, 16 different studies, unpublished and published, from 10 different
taxonomic groups)) to arrive at a value of 7.5 μg/L, which is divided by an uncertainty
factor of 5, resulting in a PNEC of 1.5 μg/L (Ref. 7).
This PNEC was derived by using a lowest observed effect concentration (LOEC) of 1.75
μg/L for reduced semen quality and delayed ovulation in a brown trout study
(Lahnsteiner et al. 2005) and applying an uncertainty factor of 10 (Ref. 6).
available at https://www.epa.gov/quality/
informationguidelines/iqg-list.html.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
PO 00000
Frm 00036
Fmt 4702
Sfmt 4702
E:\FR\FM\26JYP1.SGM
26JYP1
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
44539
TABLE 1—SUMMARY OF BISPHENOL A ECOLOGICAL VALUES—Continued
Predicted no effect
concentrations
(microgram/Liter
(μg/L)) 1
Country
Japan .....................................
1.6
Endpoints
The PNEC was derived by using the 16 μg/L no effect concentration (NOEC) for egg
hatchability in fathead minnows from the unpublished 3-generation study by Sumpter,
et al. (2001) multi-generation fish study and dividing by an uncertainty factor of 10
(Ref. 8).
1 In the European Union, Canada, and Japan, a predicted no effect concentration (PNEC) is compared directly with an exposure value to
evaluate risk. If the ratio of environmental concentration to PNEC is less than one, the risk is generally considered acceptable. As noted in the
table, countries use different approaches for generating PNECs, and the precise values may differ even when based on the same studies.
EPA considers that the uncertainty
demonstrated by these divergent
opinions concerning interpretation of
the results of existing environmental
toxicity studies, particularly studies
addressing potential effects at low levels
of exposure, may indicate further testing
is necessary to resolve the question of
whether or not BPA presents an
unreasonable risk of injury to the
environment on the basis of those
effects. This is due to the combination
of the existence of measured values, as
discussed in Unit II.B.4. and as shown
in that unit’s Table 3, for BPA in U.S.
surface waters at a mean-concentration
range of up to 1.78 μg/L (parts per
billion (ppb)) and a single-maximum
concentration of 12 μg/L (ppb); in
ground water at a mean-concentration
range of up to 1.9 μg/L (ppb) and a
maximum concentration of 2.55 μg/L
(ppb); and in freshwater sediments at a
median concentration of 0.6 μg/kg (ppb)
dry weight and a maximum
concentration of 140 μg/kg (ppb) (see
Table 3 in Unit II.B.4.), and the
existence of many hazard studies
describing a variety of effects in aquatic
organisms at some of these
concentrations (see Table 2 in Unit
II.B.2.), leaving little or no room for a
reasonable or acceptable margin of
exposure.
In order to assess the potential for
BPA to harm the environment in the
United States, EPA considers it
important to address two basic areas of
inquiry relevant to identifying the
hazard and exposure components of a
risk analysis:
a. What additional hazard information
is needed to fully characterize the
effects of BPA in environmental
organisms at low doses and potentially
environmentally relevant
concentrations?
b. What levels of BPA are present in
the environment, particularly in areas
where environmental exposures are
likely to be highest (e.g., near BPA
manufacturing facilities, polycarbonate
and epoxy resin manufacturing and
processing facilities, foundries,
landfills, wastewater treatment plants
(WWTPs), and other locations
associated with uses and/or releases of
BPA)?
2. What additional hazard
information is needed on the effects of
BPA on environmental organisms? EPA
performed a literature search to identify
relevant scientific information to assess
the acute and chronic toxicity of BPA to
environmental organisms from 2007 2 to
the present. A total of 468 articles were
found (Ref. 13), of which 30 were found
to be of some relevance (Ref. 14). Since
thorough analyses of acute and chronic
toxicity for ‘‘conventional endpoints’’
(which generally address immediate
effects on survival or reproduction) had
already been conducted for BPA by
Canada, the EU, and Japan (Refs. 6–8),
EPA performed a more detailed
evaluation of the scientific literature for
sub-lethal effects at lower
concentrations (< 100 μg/L). These sublethal effects in both vertebrates and
invertebrates could be mediated either
through endocrine or non-endocrinerelated mechanisms. There are many
studies indicating such sub-lethal
effects from BPA exposures at levels
that, based on the information discussed
in Unit II.B.4., appear to be potentially
environmentally relevant concentrations
because they may occur in the
environment. Some of these studies are
included in Table 2 of this unit.
TABLE 2—SUMMARY OF REPORTED HAZARD EFFECTS OF BISPHENOL A AT POTENTIALLY ENVIRONMENTALLY RELEVANT
CONCENTRATIONS
Endpoint
Effect
concentrations
(microgram/Liter (μg/L))
Inhibited metamorphosis via T3 pathways ...
22.8 ..................................
Heimeier et al., 2009.
High ratio of females to males—1st study ...
High ratio of females to males—2nd study ..
23 .....................................
only at 23 .........................
Levy et al., 2004.
Levy et al., 2004.
Delayed development of wattle, comb, and
testes.
Inhibited development of seminiferous tubuli
and spermatogenesis.
2 .......................................
Furuya et al., 2006.
20 .....................................
Furuya et al., 2006.
Increased vitellogenin production .................
10 .....................................
Correia et al., 2007.
Test organism
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
Amphibians:
Xenopus
laevis
(African
clawed frog).
Xenopus laevis ......................
Xenopus laevis ......................
Avian:
Gallus domesticus (chicken)
Gallus domesticus .................
Fish:
Dicentrarchus
(seabass).
labrax
2 The starting date of 2007 was used to allow for
some overlap between the thorough searches done
by Canada, the EU, and Japan.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
PO 00000
Frm 00037
Fmt 4702
Sfmt 4702
E:\FR\FM\26JYP1.SGM
26JYP1
References
(Listed in Ref. 14)
44540
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
TABLE 2—SUMMARY OF REPORTED HAZARD EFFECTS OF BISPHENOL A AT POTENTIALLY ENVIRONMENTALLY RELEVANT
CONCENTRATIONS—Continued
Endpoint
Effect
concentrations
(microgram/Liter (μg/L))
Increased vitellogenin production .................
10 .....................................
Lv et al., 2007.
13 only .............................
50 .....................................
Yokota et al., 2000.
Metcalfe et al., 2001.
Orizias latipes ........................
Orizias latipes ........................
Orizias latipes ........................
Egg hatchability delayed ..............................
Loss of testicular structure, increased fibrotic tissue; decreased sperm cells.
Vitellogenin production .................................
Increased female proteins (i.e., vitellogenin)
Decreased egg hatching in 2nd generation
10 .....................................
10 .....................................
2 only ...............................
Orizias latipes ........................
Increased male hepatosomatic index ..........
49.7 ..................................
Pimephales promelas (fathead minnow).
Xiphophorus helleri (swordtail
fish).
Cyprinus carpio (carp) ...........
Increased vitellogenin production .................
52.8 ..................................
Reduced sword tail length ............................
20 .....................................
Kashiwada et al., 2002.
Tabata et al., 2001.
Japanese Ministry of the Environment, 2006.
Japanese Ministry of the Environment, 2006.
Rhodes et al., 2007 (unpublished).
Kwak et al., 2001.
Oviduct formation in males ..........................
32 .....................................
Altered sex steroid levels; alterations in testes structure; oocyte atresia.
1 .......................................
Bowmer & Gimeno, 2001 (unpublished).
Mandich et al., 2007.
Enzyme activities in gills and digestive
glands.
Superfeminization .........................................
1 .......................................
Li et al., 2008.
1 .......................................
Oehlmann et al., 2000.
egg and clutch production per fe-
0.25 at 20 °C ....................
Oehlmann et al., 2006.
egg production .............................
clutch production .........................
growth/embryo production ...........
0.25 at 27 °C ....................
5 at 27 °C .........................
5 only ...............................
Oehlmann et al., 2006.
Oehlmann et al., 2006.
Jobling et al., 2004.
Unshelled embryos .......................................
Increased embryo production .......................
Superfeminization; reduced sperm/penis
length/prostrate gland in males.
Increased egg production .............................
Delayed development (Parent) ....................
30 .....................................
1 .......................................
1 .......................................
Duft et al., 2003.
Duft et al., 2003.
Oehlmann et al., 2000.
20 (day 10 only) ...............
0.1 ....................................
Andersen et al., 1999.
Marcial et al., 2003.
Delayed development (F1) ...........................
Delayed emergence (2nd generation) .........
Mouthpart deformities ...................................
0.01 ..................................
0.078 ................................
0.01 ..................................
Marcial et al., 2003.
Watts et al., 2001.
Watts et al., 2003.
Test organism
Misgurnus
anguillicaudatus
(Chinese loach).
Orizias latipes (medaka) ........
Orizias latipes ........................
Cyprinus carpio ......................
Invertebrates:
Bellamya purificata (snail) .....
Marisa cornuarietis (ramshorn
snail).
Marisa cornuarietis ................
Marisa cornuarietis ................
Marisa cornuarietis ................
Potamopyrgus antipodarum
(snail).
Potamopyrgus antipodarum ..
Potamopyrgus antipodarum ..
Nucella lapillus (marine snail)
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
Acartia tonsa (copepod) ........
Tigriopus japonicus (intertidal
copepod).
Tigriopus japonicus ................
Chironomus riparius ..............
Chironomus riparius ..............
Increased
male.
Increased
Increased
Increased
There is debate in the scientific
literature on how best to interpret these
low-dose, sub-lethal effects of BPA and
other chemicals on environmental
organisms. EPA is concerned that these
sub-lethal effects may be having a
detrimental effect on populations of
aquatic organisms over time based on
the reported increased susceptibility of
subsequent generations exposed to BPA
in multi-generation invertebrate and fish
studies. For example, in the intertidal
copepod (Tigriopus japonicus), delayed
development was reported in the first
generation at 0.1 μg/L, but at a 10-fold
lower concentration of 0.01 μg/L in the
next generation (Ref. 15). In the
freshwater midge (Chironomus
riparius), the first generation did not
have a significant delay in emergence
time from the egg, but in the second
generation emergence was delayed at
0.08 μg/L (Ref. 16). Egg hatchability
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
decreased in fathead minnows
(Pimephales promelas) at 640 μg/L in
the first (F1) generation, then at 160
μg/L in the second (F2) generation (Ref.
17). Although the mechanisms of action
leading to effects may be different for
vertebrate and invertebrate organisms,
this suggests the potential for increasing
developmental and reproductive effects
in populations of aquatic organisms that
have repeated exposures to BPA for
generations, even at very low
concentrations.
Testing with BPA has been extensive
at sub-lethal concentrations, but the
studies with effects across multiple
species generally have flaws associated
with them, including lack of analytical
monitoring, small sample size,
inadequate replication, or use of
inappropriate statistical analyses
leading to incorrect conclusions of
study results. Studies in ramshorn
PO 00000
Frm 00038
Fmt 4702
Sfmt 4702
References
(Listed in Ref. 14)
snails, for example, resulted in
superfeminization (e.g., the formation of
additional female organs, enlarged
accessory sex glands, gross
malformations of the pallial oviduct,
and a stimulation of egg and clutch
production) at very low concentrations
in one lab (Ref. 18), but those results
were not found in studies by other
researchers (Refs. 19–21).
In addition, in some studies, BPA
demonstrated effects at very low
concentrations, but no effects were
observed at the higher test
concentrations. For example, tadpoles
exposed to 2.3, 23, and 230 μg/L of BPA
(Ref. 22) before metamorphosis had an
increased female to male ratio at 23
μg/L only. These types of anomalous
responses have been reported across
multiple species of fish and
invertebrates for BPA and are
characteristic of endocrine-active
E:\FR\FM\26JYP1.SGM
26JYP1
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
chemicals. They suggest inhibition of
reproduction and development at low
concentrations and overcompensation
by the organism at higher
concentrations in response to a toxicant
(Ref. 23).
It is difficult to interpret this
information in a regulatory context,
because the scientific methods
employed in individual academic
settings to test a hypothesis are not
necessarily geared toward meeting or
establishing generally applicable
guidelines for evaluating ecotoxicity
and setting corresponding regulatory
limits or controls. In terms of
environmental toxicity, EPA considers
the currently available research as
evidence that BPA has the potential to
interact with the estrogen hormone
system. There is some evidence that
BPA is also active via the thyroid
hormone pathway in amphibians and
fish (Refs. 24 and 25). More recent
evidence indicates that BPA also acts as
an androgen receptor antagonist in both
mammals and fish (Ref. 26). There are
currently efforts underway by EPA’s
Office of Science Coordination and
Policy (OSCP) through the Endocrine
Disruptor Screening Program (EDSP)
and the Organization for Economic
Cooperation and Development (OECD)
Endocrine Disrupter Testing and
Assessment Work Group (EDTAWG),
among others, to determine the best
approach to evaluate and assess such
effects (Refs. 27–29).
EPA is inviting comment on the need
to further determine the hazard of BPA
to various ecological species. The
purpose of further testing would be to
produce high quality data that could be
used for risk assessment purposes for
any adverse reproductive or
developmental effects in different
species that might result from the
interactions identified through the
available research.
3. What are the issues for comment
concerning toxicity testing? EPA invites
comment on whether and what testing
should be required to further describe
the hazard of BPA to various ecological
species to resolve the low dose effects
issue. EPA particularly invites comment
on the following, for which little or no
clarifying hazard information appears to
be currently available or for which
much of the available data have been
derived from studies of questionable
quality or uncertain interpretation:
a. Effects of BPA on fish in long-term
tests, including those that encompass
multiple generations.
b. Effects of BPA on amphibians at
sensitive life stages, specifically
metamorphosis (thyroid effects) and
sexual development/differentiation
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
(hypothalamic-pituitary-gonadal axis
effects).
c. Effects of BPA on birds over
multiple generations.
d. Effects of BPA on aquatic
invertebrate species.
EPA further invites comment on the
availability of current test guidelines
that could help address these issues.
This may include, for example,
considering the draft recommendations
concerning aquatic life criteria for
contaminants of emerging concern (Ref.
30). Additionally, EPA is inviting the
public to describe and define where
they believe there are data gaps
concerning the environmental toxicity
of BPA, especially at low
concentrations, or whether and on what
basis they believe the current data are
sufficient to determine whether BPA
does or does not present an
unreasonable risk of injury to the
environment.
4. What levels of BPA are present in
the U.S. environment? BPA is present in
the environment as a result of direct
releases from manufacturing or
processing facilities (Ref. 31). BPA also
may be present in the environment as a
result of fugitive emissions during
processing and handling, release of
unreacted monomer from products (Ref.
9), or possibly from degradation of
products under certain conditions. In
addition, although no environmental
studies on thermal paper have been
done in the United States, based on
information from EPA’s review of
European and Japanese studies, the use
of unconjugated BPA in thermal paper
also may contribute to environmental
releases of BPA from paper
manufacturing and recycling plants and
to the presence of BPA in the stream of
recycled paper used in toilet paper,
paper tableware, and other products,
and may contribute to the presence of
BPA in landfills because paper products
are a major contributor to the U.S. solid
waste stream (Refs. 7, 32–36).3
Significant research has been done to
document widespread human
population exposures to BPA in the
United States using biomonitoring (Refs.
37–41). Although these studies and
reports indicate that most people in the
United States have measurable levels of
BPA in their bodies, these data do not
identify the relative source
contributions to BPA exposure.
3 Recent studies also indicate thermal paper may
contribute directly to human exposure to BPA
through dermal contact. In one U.S. study, for
example, pregnant women who worked as cashiers,
who presumably had frequent contact with thermal
paper used in cash register receipts, had the highest
urinary BPA concentrations compared with
pregnant women in other occupations (Ref. 37).
PO 00000
Frm 00039
Fmt 4702
Sfmt 4702
44541
Researchers generally accept that food
contact uses of materials containing
BPA, such as polycarbonate bottles or
epoxy linings in food and beverage cans,
are a likely major source of human
exposure, but the relative contributions
of food contact uses, potential TSCA
uses, or other environmental sources
cannot be extrapolated reliably from
these existing data. For information
about the multi-agency effort to evaluate
the potential human health
consequences of BPA exposures, see the
discussion in Unit II.B.
According to the Toxics Release
Inventory (TRI) Database, total release of
BPA in the United States in 2007 was
1,132,062 pounds (lbs), with releases of
122,965 lbs to air, 6,246 lbs to water,
14,972 lbs released on-site to land, and
684,638 lbs transferred off-site to land.
An additional 32,928 lbs were reported
as off-site water transfer to Publicly
Owned Treatment Works (POTWs), with
another 2,759,705 lbs transferred to
incineration (Ref. 31).
Some information is available for BPA
concentrations in U.S. water and other
environmental media (see Table 3 in
Unit II.B.4., providing values from the
U.S. studies cited in this discussion).
Most environmental monitoring results
show that the concentrations of BPA in
surface water bodies are lower than 1
μg/L (ppb), mainly due to its
partitioning and biodegradability
properties (Ref. 42). BPA was detected
at a median concentration of 0.14 μg/L
(ppb) and a maximum concentration of
12 μg/L (ppb) in 41.2% of 85 samples
collected from U.S. streams in 1999 and
2000 (Ref. 43). The maximum
concentration of 12 μg/L (ppb) was
much higher than any of the other
samples reported in the study; the next
highest concentration reported was 5.2
μg/L (ppb), and as indicated by the
median concentration of 0.14 μg/L
(ppb), BPA concentration in other U.S.
waters was much lower. A recent review
of reports of BPA in surface water found
that BPA was reported in 26 studies in
North America (2 in Canada and 24 in
the United States) with detection in
80% (852 of 1,068) of surface water
samples. The median concentration
reported was 0.081 μg/L (ppb) and the
95th percentile concentration was 0.47
μg/L (ppb) (Ref. 44).
Two studies have addressed
individual WWTPs in two different
parts of the United States. In 2001 and
2002, BPA was not detected above the
detection limit of 0.0001 μg/L (ppb) in
Louisiana in effluent from a WWTP, in
samples collected from surface waters in
Louisiana, or in drinking water at
various stages of treatment at plants in
Louisiana (Ref. 45). A 2008 study
E:\FR\FM\26JYP1.SGM
26JYP1
44542
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
sampled BPA in treated wastewater
from the East Bay Municipal Utilities
WWTP in Oakland, California, and in a
variety of locations that discharge to this
WWTP (Ref. 46). This study reported
detecting (limit of detection = 0.25
μg/L (ppb)) BPA in two of three treated
wastewater samples at 0.38 and 0.31
μg/L (ppb). It also reported detecting
BPA in wastewater generated by a
pharmaceutical manufacturer (0.295
μg/L (ppb)), an industrial laundry (21.5
μg/L (ppb)), and a paper products
manufacturer (0.753 μg/L (ppb)).
While U.S. studies on wastewater are
limited to only two State locations, a
Canadian study published in 2000
reported BPA concentrations ranging
from 49.9 to 0.031 μg/L (ppb) in sewage
influent and effluent (generally < 1
μg/L (ppb) in the influent and < 0.3 μg/
L (ppb) in the effluent) and from 36.7 to
0.104 μg/g (ppm) in raw and digested
sewage sludge from multiple WWTPs in
Canada (Ref. 47). The same authors
reported that BPA contamination was
detected in 100% of sewage samples
from 31 WWTPs across Canada with
concentrations ranging from 0.080 to
4.98 μg/L (ppb) (median 0.329 μg/L
(ppb)) for the influent and from 0.010 to
1.08 μg/L (ppb)(median 0.136 μg/L
(ppb)) for the effluent (Ref. 48). Based
on comparison of influent and effluent
levels, they estimated that BPA in the
influent was removed by the sewage
treatment process with a median
reduction rate of 68%. BPA was
detected in sludge samples at
concentrations ranging from 0.033 to
36.7 μg/g (ppm), on a dry weight basis.
The authors also reported a wide range
of BPA in wastewater discharges from
industrial facilities in the Toronto,
Canada, area, with concentrations
ranging from 0.23 to 149.2 μg/L (ppb).
Higher BPA levels in wastewater were
associated with facilities producing
chemicals and chemical products and
packaging and paper products, and with
commercial dry cleaning
establishments. BPA concentrations in
pulp and paper mill sludge ranged from
< 0.02 (below detection limit) to 3.33
μg/g (ppm), with a median value of
0.076 μg/g (ppm), on a dry weight basis
(Ref. 48). EPA notes that U.S.
wastewater treatment conditions and
industrial and commercial discharges
may differ from what was found in
Canada, but considers this Canadian
study to be informative.
Municipal wastewater treatment
produces solid byproducts, commonly
referred to as sewage sludge. After
additional treatment to meet regulatory
standards for pathogen, nutrient, and
metal content, this treated sewage
sludge, now classified as biosolids, may
be disposed of by land application;
biosolids may also be incinerated or
disposed of in landfills. A U.S. study
published in 2006 measured BPA in 9
treated biosolids products from WWTPs
in 7 States and found that all contained
between 1,090 and 14,400 μg/kg (ppb)
(median 4,690 μg/kg (ppb)) (Ref. 49). A
2008 study reported BPA in treated
biosolids from a municipal U.S. WWTP
at 4,600 μg/kg (ppb) and reported 81 μg/
kg (ppb) in soil that received the landapplied biosolids (Ref. 50). That study
detected BPA at 81 μg/kg (ppb) in
earthworms living in treated soil. The
authors also reported detecting 147 μg/
kg (ppb) in a nearby ‘‘control’’ soil that
did not receive treatment with biosolids.
That anomalous result was not
explained.
In 2000, the U.S. Geological Survey
(USGS) collected samples from 47
ambient ground water sites (not
drinking water wells) in 18 States and
analyzed them for 65 organic
wastewater contaminants. BPA was
detected in 29.8% of the sampled
ground water sites, with a mean
detected concentration of 1.78 μg/L
(ppb) and a range of 1.06 to 2.55 μg/L
(ppb). BPA was among the top 5 most
frequently detected organic compounds
in this study (Refs. 51 and 52).
In the summer of 2001, the USGS
collected samples from 74 sources of
raw, untreated, drinking water in 25
States and Puerto Rico, in areas that
were known or suspected to have at
least some human and/or animal
wastewater sources in upstream or
upgradient areas. These sources
comprise 25 ground water and 49
surface water sources of drinking water
serving populations ranging from one
family to more than 8 million people.
BPA was detected in 9.5% of these
samples at a reporting level of 1 μg/L
(ppb). The maximum concentration
measured in these samples was 1.9 μg/
L (ppb) (Refs. 51 and 53).
Landfill leachate from one U.S. study
reported maximum BPA concentrations
of 1.7 μg/L (ppb) in landfill leachate and
1.4 μg/L (ppb) in the receiving ground
water plume at a landfill on Cape Cod,
Massachusetts, that was known to be
leaking (Ref. 54). Data for other landfill
sites in the United States were not
available, and this single point is not
representative of the country. Landfill
leachate from other countries contained
more than 500 μg/L (ppb) of BPA (Ref.
42). Studies conducted at Japanese
landfills resulted in maximum untreated
leachate concentrations of 17,200 μg/L
(ppb) and treated leachate
concentrations of 5.1 μg/L (ppb) (Ref.
11).
Wilson et al. (Ref. 55) reported that
BPA concentrations in soil samples
taken from outdoor play areas of homes
and daycare centers ranged from 4–14
ppb dry weight, with means of 6–7 ppb
dry weight. Klecka et al. (Ref. 44)
reported a median concentration of 0.6
ppb BPA in North American freshwater
sediments, including non-detected
samples; BPA concentrations in samples
from the United States ranged from 1.4
to 140 ppb dry weight. Levels in U.S.
marine sediments were reported to have
a median of 3.5 ppb of BPA and to range
from 1.5 to 5 ppb dry weight (Ref. 56).
TABLE 3—U.S. REPORTED ENVIRONMENTAL CONCENTRATIONS OF BISPHENOL A
Mean or range of means
(parts per
billion (ppb))
Range (ppb)
Surface Water ......................
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
Location
<0.0001 to 0.14* ................
<0.0001 to 12 ....................
Ground Water ......................
NR** to 1.78 † ....................
<0.003 to 2.55 ...................
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
PO 00000
Frm 00040
Fmt 4702
Sfmt 4702
References
Barnes et al., 2008a (Ref. 51).
Boyd et al., 2003 (Ref. 45).
Boyd et al., 2004 (Ref. 57).
Focazio et al., 2008 (Ref. 53).
Klecka et al., 2009 (Ref. 44).
Kolpin et al., 2002 (Ref. 43).
Staples et al., 2000 (Ref. 58).
Zhang et al., 2007 (Ref. 59).
Barnes et al., 2008a (Ref. 51).
Barnes et al., 2008b (Ref. 52).
Focazio et al., 2008 (Ref. 53).
Rudel et al., 1998 (Ref. 54).
E:\FR\FM\26JYP1.SGM
26JYP1
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
44543
TABLE 3—U.S. REPORTED ENVIRONMENTAL CONCENTRATIONS OF BISPHENOL A—Continued
Location
Mean or range of means
(parts per
billion (ppb))
Range (ppb)
Drinking Water .....................
<0.0001 .............................
<0.0001 to 0.42 .................
Wastewater ..........................
<0.0001 .............................
<0.0001 to 25 ....................
Soils .....................................
6 to 7 .................................
4 to 147 .............................
Sediment, Fresh ..................
Sediment, Marine ................
Biosolids ..............................
0.6* †† ................................
3.5* ....................................
4,600 to 4,690* ..................
1.4 to 140 †† ......................
1.5 to 5.0 ...........................
1,090–14,400 .....................
References
Boyd et al., 2003 (Ref. 45).
Stackelberg et al., 2004 (Ref. 60).
Boyd et al., 2003 (Ref. 45).
Drewes et al., 2005 (Ref. 61).
Jackson and Sutton, 2008 (Ref. 46).
Rudel et al., 1998 (Ref. 54)
Tsai, 2006 (Ref. 42).
Kinney et al., 2008 (Ref. 50).
Wilson et al., 2003 (Ref. 55).
Klecka et al., 2009 (Ref. 44).
Stuart et al., 2005 (Ref. 56).
Kinney et al., 2006 (Ref. 49).
Kinney et al., 2008 (Ref. 50)
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
* Value is median.
** Not reported (NR).
† Mean of values above reporting limit (1 ppb).
†† Median value includes non-detected values below the minimum detection limit, while the reported range includes only detected values.
Although there is disagreement in
interpreting some of the effects observed
in studies performed to date with BPA,
as described in Unit II.B.1. and 2., a
comparison of the range of the effect
levels observed in many studies and the
predicted no effect concentration
(PNEC) values used in three
international regulatory risk
assessments (0.175 to 1.6 μg/L, Table 1
of Unit II.B.1.) with measured
concentrations in some U.S. waters and
sediments, which included values as
high as 12 μg/L (ppb) (surface water),
2.55 μg/L (ppb) (ground water), and 140
ppb sediment (freshwater sediment)
(Table 2 of Unit II.B.2.), indicate
possible risk of injury to aquatic
organisms. The single available
measurement of BPA in leachate from
one U.S. landfill site is not sufficient to
represent or characterize the United
States as a whole, and landfill leachate
data from other countries suggest that
BPA concentrations in leachate may be
significantly higher than concentrations
in surface water bodies. The direct
exposure pathway from wastewater to
environmental organisms, along with
the widespread detection of BPA in
WWTP sludges, further suggest that
land application of WWTP sludges may
be a significant environmental exposure
pathway that needs to be better
understood.4
Although most currently available
environmental monitoring results show
that the concentrations of BPA in U.S.
water bodies are lower than 1 μg/L (ppb)
(median concentration of 0.14 μg/L
4 EPA’s response to the request for correction of
the information provided in the Action Plan that
was filed under the ‘‘Agency’s Information Quality
Guidelines’’ by the American Chemistry Council is
available at https://www.epa.gov/quality/
informationguidelines/iqg-list.html.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
(ppb)), these environmental
measurements represent isolated
snapshots in time. Because these results
come from a variety of studies designed
for very different purposes and
conditions (for example, laboratory
analytical development contrasted with
field monitoring), the data are not
readily comparable and cannot be
assembled into a nationally or
regionally representative picture.
Particularly in light of the
corresponding uncertainties described
in Unit II.B.1. and 2., concerning
potential BPA hazards at low doses, the
existing data do not allow EPA to
determine how many areas may exceed
potential concentrations of concern,
how often or how long such
concentrations may be exceeded, or the
sources or pathways leading to BPA
presence in the environment from
manufacturing, processing, distribution
in commerce, use, or disposal that may
result in human and environmental
exposures. EPA considers that these
existing data would not be sufficient to
determine whether or not an
unreasonable risk to the environment
exists. To help resolve these
uncertainties, EPA is considering
requiring that manufacturers and
processors of BPA conduct
environmental testing consisting of
targeted sampling and monitoring of
surface water, ground water, sediment,
soil, landfill leachate, and drinking
water on and adjacent to their
properties, specifically in the vicinity of
manufacturing facilities and such
processing facilities as foundries,
WWTPs, paper and plastics recycling
facilities, and other sources of BPA
releases as identified through TRI
reporting and other information. These
PO 00000
Frm 00041
Fmt 4702
Sfmt 4702
test data could also help guide
development of effective risk
management actions if it should be
determined that activities involving
BPA present an unreasonable risk of
injury to aquatic or other environmental
systems.
Fully understanding exposure
pathways and in particular the
magnitude, frequency, and duration of
exposure could require a nationwide
survey of the occurrence of the chemical
in environmental media associated with
production, processing, use, disposal,
and recycling facilities. However, at this
time, EPA is proposing that selected
monitoring of a more limited scope be
conducted to help identify the most
likely locations of high exposure and
the sources and pathways of exposure,
to determine whether BPA may be
present in those locations at
concentrations that pose a risk of
concern to aquatic or other systems.
Monitoring of aquatic sites and
sediments near releases (effluents and
sludge) from manufacturing and
processing sites (including on-site
WWTPs) reporting high releases under
TRI or associated with high releases
identified from other information, as
well as monitoring of sites that receive
runoff from landfills, would be
included.
EPA believes these targeted
monitoring data may provide
information relevant both to the
characterization of environmental risk
and to the potential focus of future risk
management activities such as those
under TSCA section 6, if the data
indicate such activities are warranted.
EPA also considers these data would
further inform the issue of potential
human exposure levels attributable to
sources other than the direct food
E:\FR\FM\26JYP1.SGM
26JYP1
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
44544
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
contact uses believed to be the principal
source of human exposure, which are
regulated by the FDA. As noted earlier
in Unit II.B., EPA is working with FDA,
NIEHS, and CDC on additional research
to better determine and evaluate the
potential human health consequences of
exposures to BPA, including exposures
at low doses. Levels of exposure that
may be identified by FDA as being of
concern to human health, including
children’s health, would affect the
extent to which EPA would take
additional action to address potential
risks to human health resulting from
uses within TSCA jurisdiction, but EPA
is not considering any additional testing
specifically in regard to human health
issues at this time.5
In order to be useful to an
investigation of potential environmental
risks posed by BPA, environmental
testing must be representative and of
known quality. To accomplish this, data
should be collected using approved or
recognized sampling, preparation, and
analytical techniques. Appropriate
quality assurance and quality controls
also should be incorporated in the
protocols for collection and analyses.
A further complicating factor in the
assessment of potential environmental
risks posed by BPA is that organisms in
the environment, rather than being
exposed to a single chemical at a time,
are likely to be exposed simultaneously
to multiple chemicals. The presence of
other endocrine-active chemicals,
including other estrogenic chemicals,
for example, could affect the potential
for effects on environmental organisms.
It may be useful, when monitoring for
BPA, to identify the total estrogenicity
of a sample along with the amount of
BPA present.
Potential methodologies and protocols
for use in monitoring programs may
include ASTM D7574–09 Standard Test
Method for Determination of Bisphenol
A in Environmental Waters by Liquid
Chromatography/Tandem Mass
Spectrometry (Ref. 62); ASTM D5730–
04 Standard Guide for Site
Characterization for Environmental
Purposes With Emphasis on Soil, Rock,
the Vadose Zone and Ground Water
(Ref. 63); EPA Method 8270D (SW–846),
Semivolatile Organic Compounds by
Gas Chromatography/Mass
Spectrometry (GC/MS), Revision 4 (Ref.
64); and other methods cited and
described in such publications as
Barnes et al. (2008) (Ref. 51) and
Focazio et al. (2008) (Ref. 53).
5 EPA notes, however, that information obtained
on the environmental presence of BPA would be
relevant to understanding the environmental
component of human exposures.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
5. What are the issues for comment
concerning environmental testing
consisting of sampling and monitoring?
EPA particularly invites comment on:
a. The extent and type of
environmental testing that may be
sufficient to characterize the
environmental presence of BPA.
b. The extent and type of
environmental testing that may be
sufficient to understand sources of and
exposure from the high concentrations
of BPA found in treated biosolids from
WWTPs.
c. Whether environmental testing
should be conducted now, or should be
tiered to occur after the uncertainties
associated with the hazards of BPA at
low concentrations in the environment
have been resolved.
d. The locations where such
environmental testing should be
undertaken, such as manufacturing,
processing, recycling, foundry, and
other use, treatment, and disposal sites
identified with BPA releases reported
under TRI or other information.
e. The media (e.g., soil, sediment,
sludge, WWTP influent and effluent,
landfill leachate, drinking water, surface
water, ground water) to be sampled at
each such site.
f. Which parties should be required to
conduct the testing and/or be
potentially responsible for providing
reimbursement to those who conduct
specific tests.
g. The appropriate methods and
protocols to use in such a
environmental testing program.
h. Whether such an environmental
testing program should include
measurements for the total estrogenicity
of samples collected as well as for the
concentration of BPA, and what
methods and protocols may be suitable
for generating and interpreting such
data.
i. Whether and what additional
environmental testing activities may be
necessary to understand and
characterize non-food-contact uses,
sources, and environmental pathways
that may contribute to exposure to BPA.
Though, as indicated in Unit II.B., the
current focus of this ANPRM is on
environmental effects, this information
would inform the multi-agency effort to
evaluate the potential human health
consequences of BPA exposures.
j. Other information that may provide
insight into sources and pathways of
environmental and human exposure to
BPA released into the environment.
Though, as indicated in Unit II.B., the
current focus of this ANPRM is on
environmental effects, this information
would inform the multi-agency effort to
PO 00000
Frm 00042
Fmt 4702
Sfmt 4702
evaluate the potential human health
consequences of BPA exposures.
k. The cost and economic feasibility
of such environmental testing, for the
different types of sites.
C. What is the agency’s authority for
taking this action?
EPA is issuing this ANPRM on certain
toxicity testing and on certain
environmental testing consisting of
sampling and monitoring for the
chemical substance BPA under TSCA
section 4(a) (15 U.S.C. 2603(a)).
Section 2(b)(1) of TSCA (15 U.S.C.
2601(b)) states that it is the policy of the
United States that ‘‘adequate data
should be developed with respect to the
effect of chemical substances and
mixtures on health and the environment
and that the development of such data
should be the responsibility of those
who manufacture [which is defined by
statue to include import] and those who
process such chemical substances and
mixtures[.]’’ To implement this policy,
TSCA section 4(a)(1) provides that EPA
shall require by rule that manufacturers
or processors or both of chemical
substances and mixtures conduct
testing, if the Administrator finds in a
final rule that:
(A)(i) the manufacture, distribution in
commerce, processing, use, or disposal of a
chemical substance or mixture, or that any
combination of such activities, may present
an unreasonable risk of injury to health or the
environment,
(ii) there are insufficient data and
experience upon which the effects of such
manufacture, distribution in commerce,
processing, use, or disposal of such substance
or mixture or any combination of such
activities on health or the environment can
reasonably be determined or predicted, and
(iii) testing of such substances or mixture
with respect to such effects is necessary to
develop such data; or
(B)(i) a chemical substance or mixture is or
will be produced in substantial quantities,
and (I) it enters or may reasonably be
anticipated to enter the environment in
substantial quantities or (II) there is or may
be significant or substantial human exposure
to such substance or mixture,
(ii) there are insufficient data and
experience upon which the effects of the
manufacture, distribution in commerce,
processing, use, or disposal of such substance
or mixture or of any combination of such
activities on health or the environment can
reasonably be determined or predicted, and
(iii) testing of such substance or mixture
with respect to such effects is necessary to
develop such data and
(C) in the case of a mixture, the effects
which the mixture’s manufacture,
distribution in commerce, processing, use or
disposal or any combination of such
activities may have on health or the
environment may not be reasonably and
more efficiently determined or predicted by
E:\FR\FM\26JYP1.SGM
26JYP1
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
testing the chemical substances which
comprise the mixture[.]
(15 U.S.C. 2603(a))
If EPA in a final rule makes an
appropriate finding under TSCA section
4(a)(1)(A) or (B) for a chemical
substance or mixture, the Administrator
shall require that testing be conducted
on that chemical substance or mixture.
The purpose of the testing would be to
develop data with respect to the health
and environmental effects for which
there is an insufficiency of data and
experience, and which are relevant to a
determination that the manufacture,
distribution in commerce, processing,
use, or disposal of the substance or
mixture, or any combination of such
activities, does or does not present an
unreasonable risk of injury to health or
the environment. As indicated in Unit
II.A.3., EPA requests comment and
supporting information regarding which
TSCA section 4(a)(1) finding authority
would be most appropriate for the
purpose of a BPA test rule proposal.
Any proposal would ultimately be based
on EPA’s assessment of the relevant
information available at the time of
proposal.
Once the Administrator has made the
relevant findings under TSCA section
4(a), EPA may require any health or
environmental effects testing for which
data are insufficient and which are
necessary to develop the data. EPA need
not limit the scope of testing required to
the factual basis for the TSCA section
4(a)(1)(A)(i) or (B)(i) findings as long as
EPA also finds that there are insufficient
data and experience upon which the
effects of the manufacture, distribution
in commerce, processing, use, or
disposal of such substance or mixture or
of any combination of such activities on
health or the environment can
reasonably be determined or predicted,
and that testing is necessary to develop
such data. This approach is explained in
more detail in EPA’s TSCA section
4(a)(1)(B) Final Statement of Policy (B
Policy) published in the Federal
Register issue of May 14, 1993 (58 FR
28736, 28738–28739).
Authority for requiring sampling and
monitoring for a chemical substance or
mixture can be found within TSCA
section 4. Section 4(a) of TSCA
authorizes EPA to require the
development of data ‘‘which are
relevant to a determination that the
manufacture, distribution in commerce,
processing, use, or disposal of such
substance or mixture, or that any
combination of such activities, does or
does not present an unreasonable risk of
injury to health and the environment.’’
The extent to which such activities may
affect health or the environment is
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
dependent in part upon the human and
environmental exposures to the
chemical substance occasioned by those
activities. As an example, TSCA section
4(a)(2)(A) specifically addresses testing
for persistence of a substance. Testing to
identify where and in what
concentrations a chemical substance or
mixture may become present in the
environment contributes to an
understanding of human and
environmental exposures resulting from
those activities. As stated in Unit II.B.,
EPA does not intend to initiate
regulatory action under TSCA at this
time on the basis of human health.
III. References
1. EPA. 2010. Bisphenol A Action Plan.
Available on-line at https://
www.regulations.gov/#!document
Detail;D=EPA-HQ-OPPT-2010-03480002.
2. EPA. 1993. Bisphenol A (CASRN 80–05–
7) Reference Dose for Chronic Oral
Exposure (RfD). July 1, 1993. Integrated
Risk Information System (IRIS).
Available on-line at https://www.epa.gov/
ncea/iris/subst/0356.htm.
3. FDA. 2008. Draft Assessment of Bisphenol
A for Use in Food Contact Applications.
Available on-line at https://www.fda.gov/
ohrms/dockets/AC/08/briefing/20080038b1_01_02_
FDA%20BPA%20Draft%20
Assessment.pdf. Peer review report and
additional information available on-line
at https://www.fda.gov/Food/Food
IngredientsPackaging/ucm166145.htm.
4. European Food and Safety Authority
(EFSA). 2006. Opinion of the Scientific
Panel on Food Additives, Flavourings,
Processing Aids and Materials in Contact
with Food on a Request from the
Commission Related to 2,2-BIS(4HYDROXYPHENYL) PROPANE.
Question number EFSA–Q–2005–100.
The EFSA Journal. Vol. 428:1–75.
5. EFSA. 2008. Scientific Opinion of the
Panel on Food additives, Flavourings,
Processing aids and Materials in Contact
with Food (AFC) on a request from the
Commission on the toxicokinetics of
Bisphenol A. The EFSA Journal. Vol.
759:1–10.
6. Canada. 2008. Environment Canada,
Health Canada. Screening Assessment
for the Challenge Phenol, 4,4’ (1methylethylidene)bis- (Bisphenol A)
Chemical Abstracts Service Registry
Number 80–05–7. October 2008.
Available on-line at https://www.ec.gc.ca/
substances/ese/eng/challenge/batch2/
batch2_80-05-7_en.pdf.
7. EU. 2010. European Union Risk
Assessment Report. CAS: 80–05–7.
EINECS No.: 201–245–8. Environment
Addendum of April 2008 and Human
Health Addendum of April 2008 (to be
read in conjunction with published EU
RAR of BPA, 2003). 4,4’ISOPROPYLIDENEDIPHENOL
(Bisphenol A). Institute for Health and
Consumer Protection, Joint Research
PO 00000
Frm 00043
Fmt 4702
Sfmt 4702
44545
Centre, European Commission.
Luxembourg: Publications Office of the
European Union.
8. Japan’s National Institute of Advanced
Industrial Science and Technology
(AIST). 2007. AIST Risk Assessment
Document Series 4. Bisphenol A.
AIST07–A00001–4.
9. National Toxicology Program, Center for
the Evaluation of Risks to Human
Reproduction (NTP/CERHR), HHS. 2008.
NTP–CERHR Monograph on the
Potential Human Reproductive and
Developmental Effects of Bisphenol A.
Available on-line at https://
cerhr.niehs.nih.gov/evals/bisphenol/
bisphenol.pdf.
10. FDA. 2010. U.S. Food and Drug
Administration. Update on Bisphenol A
for Use in Food Contact Applications:
January 2010. Available on-line at https://
www.fda.gov/NewsEvents/
PublicHealthFocus/ucm197739.htm.
11. Crain, D.A.; Eriksen, M.; Iguchi, T.;
Jobling, S.; Laufer, H.; LeBlanc, G.A.; and
Guillette, Jr., L.J. 2007. An ecological
assessment of Bisphenol A: evidence
from comparative biology. Reproductive
Toxicology. Vol. 24:225–239.
12. Lahnsteiner, F.; Berger, B.; Kletzl, M.; and
Weismann, T. 2005. Effect of Bisphenol
A on Maturation and Quality of Semen
and Eggs in the Brown Trout, Salmo
trutta f. fario. Aquatic Toxicology. Vol.
75:213–224.
13. EPA. 2010. List of References to BPARelated Environmental Studies
Published from 2007 through 2010.
14. EPA. 2010. List of References Published
from 2007 through 2010 of Some
Relevance to the Environmental Toxicity
of BPA, and Older Studies of Sub-Lethal
Effects Also Cited in Table 2.
15. Marcial, H.S.; Hagiwara, A.; and Snell,
T.W. 2003. Estrogenic compounds affect
development of harpacticoid copepod
Tigriopus Japonicus. Environmental
Toxicology and Chemistry. Vol. 22:3025–
3030.
16. Watts, M.M.; Pascoe, D.; and Carroll, K.
2001. Chronic exposure to 17aethinylestradiol and bisphenol A-effects
on development and reproduction in the
freshwater invertebrate Chironomus
riparius (Diptera: Chironomidae).
Aquatic Toxicology. Vol. 55:113–124.
17. Sumpter, J.P.; Tyler, C.R.; Sherazi, A.
2001. Bisphenol-A: Multigeneration
study with the fathead minnow
(Pimephales promelas). Brunel
University (unpublished; part of study
published as Sohoni et al., 2001).
18. Oehlmann, J.; Schulte-Oehlmann, U.;
Werner, K.; Jagnytsch, O.; Lutz, I.;
Kresten, K.; Wollenberger, L.; Santos,
E.M.; Paull, G.C.; Van Look, K.J.W.; and
Tyler, C.R. 2008. A Critical Analysis of
the Biological Impacts of Plasticizers on
Wildlife. Philosophical Transactions of
The Royal Society, B: Biological
Sciences. Vol. 364:2047–2062.
19. Forbes, V.E.; Selck, H.; Palmqvist, A.;
Aufderheide, J.; Warbritton, R.; Pounds,
N.; Thompson, R.; van der Hoeven, N.;
and Caspers, N. 2007. Does bisphenol A
induce superfeminization in Marisa
E:\FR\FM\26JYP1.SGM
26JYP1
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
44546
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
cornuarietis? Part I: Intra- and interlaboratory variability in test endpoints.
Ecotoxicology and Environmental Safety.
Vol. 66:309–318.
20. Forbes, V.E.; Aufderheide, J.; Warbritton,
R.; Thompson, R.; van der Hoeven, N.;
and Caspers, N. 2007. Does bisphenol A
induce superfeminization in Marisa
cornuarietis? Part II: Toxicity test results
and requirements for statistical power
analyses. Ecotoxicology and
Environmental Safety. Vol. 66:319–325.
21. Forbes, V.E; Aufderheide, J.; Warbritton,
R.; Thompson, R.; van der Hoeven, N.;
and Caspers, N. 2008. Effects of
bisphenol A on fecundity, egg
hatchability, and juvenile growth of
Maris Cornuarietis. Environmental
Toxicology and Chemistry. Vol. 27:2332–
2340.
¨
22. Levy, G.; Lutz, I.; Kruger, A.; and Kloas,
W. 2004. Bisphenol A induces
feminization in Xenopus laevis tadpoles.
Environmental Research. Vol. 94:102–
111.
23. Calabrese, E.J. and Baldwin, L.A. 2003.
Hormesis at the National Toxicology
Program (NTP): evidence of hormetic
dose responses in NTP dose-range
studies. Nonlinearity in Biology,
Toxicology, and Medicine. Vol. 1:455–
467.
24. Heimeier, R.A.; Das, B.; Buchholz, D.R.;
and Shi, Y. 2009. The Xenoestrogen
Bisphenol A inhibits postembryonic
vertebrate development by antagonizing
gene regulation by thyroid hormone.
Endocrinology. Vol. 150:2964–2973.
25. Ramakrishnan, S. and Wayne, N.L. 2008.
Impact of bisphenol-A on early
embryonic development and
reproductive maturation. Reproductive
Toxicology. Vol. 25:177–183.
26. Ankley, G.T.; Jensen, K.M.; Kahl, M.D.;
Durhan, E.J.; Makynen, E.A.; Cavallin,
J.E.; Martinovic, D.; Wehmas, L.C.;
Mueller, N.D.; and Villeneuve, D.L. 2010.
Use of chemical mixtures to differentiate
mechanisms of endocrine action in a
small fish model. Aquatic Toxicology.
Vol. 99:389–396.
27. EPA. Endocrine Disruptor Screening
Program; Policies and Procedures for
Initial Screening; Notice. Federal
Register (74 FR 17560, April 15, 2009)
(FRL–8399–9).
28. EPA. Endocrine Disruptor Screening
Program Web site. Available on-line at
https://www.epa.gov/scipoly/oscpendo.
29. Organization for Economic Co-operation
and Development Environment
Directorate. Endocrine Disruptor Testing
and Assessment. Available on-line at
https://www.oecd.org/document/62/
0,3343,en_2649_34377_2348606_1_1_
1_1,00.html.
30. EPA. 2008. White Paper. Aquatic Life
Criteria for Contaminants of Emerging
Concern. Draft Document. EPA, Office of
Water. Washington, DC.
31. EPA. 2009a. Toxics Release Inventory.
2007 Public Data Release, Released
March 14, 2009. Available on-line at
https://www.epa.gov/tri/tridata/
index.html.
¨
32. Vinggaard, A.M.: Korner, W.; Lund, K.H.;
Bolz, U.; and Petersen, J.H. 2000.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
Identification and quantification of
estrogenic compounds in recycled and
virgin paper for household use as
determined by an in vitro yeast estrogen
screen and chemical analysis. Chemical
Research in Toxicology. Vol. 13:1214–
1222.
33. Gehring, M.; Tennhardt, L.; Vogel, D.;
Weltin, D.; and Bilitewski, B. 2004.
Bisphenol A contamination of
wastepaper, cellulose and recycled paper
products. In: Brebbia, C.A.; Kungulos, S.;
Popov, V.; and Itoh, H. (eds.): Waste
Management and the Environment II.
WIT Transactions on Ecology and the
Environment. Vol. 78:294–300.
Southampton, Boston: WIT Press.
Available on-line at https://rcswww.urz.
tu-dresden.de/∼gehring/deutsch/dt/vortr/
040929ge.pdf.
34. Ozaki, A.; Yamaguchi, Y.; Fujita, T.;
Kuroda, K.; and Endo, G. 2004. Chemical
analysis and genotoxicological safety
assessment of paper and paperboard
used for food packaging. Food and
Chemical Toxicology. Vol. 42:1323–
1337.
35. Fukazawa, H.; Hoshino, K.; Shiozawa, T.;
Matsushita, H.; and Terao, Y. 2001.
Identification and quantification of
chlorinated bisphenol A in wastewater
from wastepaper recycling plants.
Chemosphere. Vol. 44:973–979.
36. Terasaki, M.; Shiraishi, F.; Fukazawa, H.;
and Makino, M. 2007. Occurrence and
estrogenicity of phenolics in paperrecycling process water: pollutants
originating from thermal paper in waste
paper. Environmental Toxicology and
Chemistry. Vol. 26:2356–2366.
37. Braun, J.M.; Kalkbrenner, A.E.; Calafat,
A.M.; Bernert, J.T.; and Ye, X., et al. 2011
Variability and Predictors of Urinary
Bisphenol A Concentrations during
Pregnancy. Environmental Health
Perspectives. Vol. 119:131–137.
38. Calafat, A.M.; Kuklenyik, Z.; and Reidy,
J.A., et al 2005. Urinary concentrations
of bisphenol A and 4-nonylphenol in a
human reference population.
Environmental Health Perspectives. Vol.
113:391–395.
39. Calafat, A.M.; Ye, S; and Wong, L.Y., et
al 2008. Exposure of the US population
to bisphenol A and 4-tertiartyoctylphenol: 2003–2004. Environmental
Health Perspectives. Vol. 116:39–44.
40. Calafat, A.M.; Weuve, J.; Ye, X., et al
2009. Exposure to bisphenol A and other
phenols in neonatal intensive care unit
premature infants. Environmental Health
Perspectives. Vol. 117:639–644.
41. CDC, HHS. Fourth National Report on
Human Exposure to Environmental
Chemicals, Update Tables. July 2010.
Available on-line at https://www.cdc.gov/
exposurereport/pdf/Update_Tables.pdf.
42. Tsai, W. 2006. Human Health Risk on
Environmental Exposure to Bisphenol-A:
A Review. Journal of Environmental
Science and Health. Part C, Vol. 24:225–
255.
43. Kolpin, D.W.; Furlong, E.T.; Meyer, M.T.;
Thurman, E.M.; Zaugg, S.D.; Barber, L.B.;
and Buxton, H.T. 2002. Pharmaceuticals,
hormones, and other organic wastewater
PO 00000
Frm 00044
Fmt 4702
Sfmt 4702
contaminants in U.S. streams, 1999–
2000: a national survey. Environmental
Science & Technology. Vol. 36:1202–
1211.
44. Klecka, G.M.; Staples, C.A.; Clark, K.E.;
van der Hoeven, N.; Thomas, D.E.; and
Hentges, S.G. 2009. Exposure Analysis of
Bisphenol A in Surface Water Systems in
North America and Europe.
Environmental Science & Technology.
Vol. 43:6145–6150.
45. Boyd, G.R.; Reemtsma, H.; Grimm, D.A.;
and Mitra, S. (2003). Pharmaceuticals
and personal care products (PPCPs) in
surface and treated waters of Louisiana,
U.S.A. and Ontario, Canada. The Science
of the Total Environment. Vol. 311:135–
149.
46. Jackson, J. and Sutton, R. 2008. Sources
of endocrine-disrupting chemicals in an
urban wastewater, Oakland, CA. The
Science of the Total Environment. Vol.
405:153–160.
47. Lee, H-B. and Peart, T.E. 2000a.
Determination of bisphenol A in sewage
effluent and sludge by solid-phase and
supercritical fluid extraction and gas
chromatography/mass spectrometry.
Journal of the Association of Analytical
Communities (AOAC) International. Vol.
83:290–297.
48. Lee, H-B. and Peart, T.E. 2000b.
Bisphenol A contamination in Canadian
municipal and industrial wastewater and
sludge samples. Water Quality Research
Journal of Canada. Vol. 35:283–298.
49. Kinney, C.A.; Furlong, E.T.; Zaugg, S.D.;
Burkhardt, M.R.; Werner, S.L.; Cahill,
J.D.; and Jorgensen, G.R. 2006. Survey of
Organic Wastewater Contaminants in
Biosolids Destined for Land Application.
Environmental Science & Technology.
Vol.l40:7207–7215.
50. Kinney, C.A; Furlong, E.T.; Kolpin, D.W.;
Burkhardt, M.R.; Zaugg, S.D.; Werner,
S.L.; Bossio, J.P.; and Benotti, M.J. 2008.
Bioaccumulation of pharmaceuticals and
other anthropogenic waste indicators in
earthworms from agricultural soil
amended with biosolid or swine manure.
Environmental Science & Technology.
Vol. 42:1863–1870.
51. Barnes, K.K.; Kolpin, D.W.; Focazio, M.J.;
Furlong, E.T.; Meyer, M.T.; Zaugg, S.D.;
Haack, S.K.; Barber, L.B.; and Thurman,
E.M. 2008a. U. S. Geological Survey.
Water-Quality Data for Pharmaceuticals
and Other Organic Wastewater
Contaminants in Ground Water and in
Untreated Drinking Water Sources in the
United States, 2000–01. Available online at https://pubs.usgs.gov/of/2008/
1293.
52. Barnes, K.K.; Kolpin, D.W.; Furlong, E.T.;
Zaugg, S.D.; Meyer, M.T.; and Barber,
L.B. 2008b. A National Reconnaissance
of Pharmaceuticals and Other Organic
Wastewater Contaminants in the United
States: (I) Groundwater. The Science of
the Total Environment. Vol. 402:192–
200.
53. Focazio, M.J.; Kolpin, D.W.; Barnes, K.K.;
Furlong, E.T.; Meyer, M.T.; Zaugg, S.D.;
Barber, L.B.; and Thurman, E.M. 2008. A
National Reconnaissance for
Pharmaceuticals and Other Organic
E:\FR\FM\26JYP1.SGM
26JYP1
wreier-aviles on DSKDVH8Z91PROD with PROPOSALS
Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Proposed Rules
Wastewater Contaminants in the United
States—(II) Untreated Drinking Water
Sources. The Science of the Total
Environment. Vol. 402:201–216.
54. Rudel, R.A.; Melly, S.J.; Geno, P.W.; Sun,
G.; and Brody, J.G. 1998. Identification of
Alkylphenols and Other Estrogenic
Phenolic Compounds in Wastewater,
Septage, and Groundwater on Cape Cod,
MA. Environmental Science &
Technology. Vol. 32:861–869.
55. Wilson, N.K.; Chuang, J.C.; Lyu, C.;
Menton, R.; and Morgan, M.K. 2003.
Aggregate exposures of nine preschool
children to persistent organic pollutants
at day care and home. Journal of
Exposure Analysis and Environmental
Epidemiology. Vol. 13:187–202.
56. Stuart, J.D.; Capulong, C.P.; Launer, K.D.;
and Pan, X. 2005. Analyses of phenolic
endocrine disrupting chemicals in
marine samples by both gas and liquid
chromatography-mass spectrometry.
Journal of Chromatography A. Vol.
1079:136–145.
57. Boyd, G.R.; Palmerib, J.M.; and Grimm,
D.A. 2004. Pharmaceuticals and Personal
Care Products (PPCPs) and Endocrine
Disrupting Chemicals (EDCs) in
Stormwater Canals and Bayou St. John in
New Orleans, Louisiana, USA. The
Science of the Total Environment. Vol.
333:137–48.
58. Staples, C.A.; Dorn, P.B.; Klecka, G.M.;
O’Block, S.T.; Branson, D.R.; and Harris,
L.R. 2000. Bisphenol A Concentrations
in Receiving Waters Near U.S.
Manufacturing and Processing Facilities.
Chemosphere. Vol. 40:521–525.
59. Zhang, S.; Zhang, Q.; Darisaw, S.; Ehie,
O.; and Wang, G. 2007. Simultaneous
Quantification of Polycyclic Aromatic
Hydrocarbons (PAHs), Polychlorinated
Biphenyls (PCBs), and Pharmaceuticals
and Personal Care Products (PPCPs) in
Mississippi River Water, in New Orleans,
Louisiana, USA. Chemosphere. Vol.
66:1057–1069.
60. Stackelberg, P.E.; Furlong, E.T.; Meyer,
M.T.; Zaugg, S.D.; Henderson, A.K.; and
Reissman, D.B. 2004. Persistence of
Pharmaceutical Compounds and Other
Organic Wastewater Contaminants in a
Conventional Drinking-Water-Treatment
Plant. The Science of the Total
Environment. Vol. 329:99–113.
61. Drewes, J.E.; Hemming, J.; Ladenburger,
S.J.; Schauer, J.; and Sonzogni, W. 2005.
An Assessment of Endocrine Disrupting
Activity Changes during Wastewater
Treatment through the Use of Bioassays
and Chemical Measurements. Water
Environment Research. Vol. 77:12–23.
62. ASTM International (ASTM). 2009.
ASTM D7574–09 Standard Test Method
for Determination of Bisphenol A in
Environmental Waters by Liquid
Chromatography/Tandem Mass
Spectrometry. Available on-line at https://
www.astm.org/Standards/D7574.htm.
63. ASTM. 2004. ASTM D5730–04 Standard
Guide for Site Characterization for
Environmental Purposes With Emphasis
on Soil, Rock, the Vadose Zone and
Ground Water. Available on-line at
https://www.astm.org/Standards/
D5730.htm.
VerDate Mar<15>2010
14:37 Jul 25, 2011
Jkt 223001
64. EPA. 1998. Method 8270D (SW–846),
Semivolatile Organic Compounds by Gas
Chromatography/Mass Spectrometry
(GC/MS), Revision 4. Available on-line at
https://www.epa.gov/sam/pdfs/EPA8270d.pdf.
IV. Statutory and Executive Order
Reviews
Under Executive Order 12866,
entitled ‘‘Regulatory Planning and
Review’’ (58 FR 51735, October 4, 1993),
this action was submitted to the Office
of Management and Budget (OMB) for
review. Any changes made to this
document in response to OMB
comments received by EPA during that
review have been documented in the
docket as required by the Executive
Order.
Since this document does not impose
or propose any requirements, and
instead seeks comments and suggestions
for the Agency to consider in possibly
developing a subsequent proposed rule,
the various other review requirements
that apply when an agency imposes
requirements do not apply to this
action. Nevertheless, as part of your
comments on this ANPRM, you may
include any comments or information
that you have regarding this action.
In particular, any comments or
information that would help the Agency
to assess the potential impact of a rule
on small entities pursuant to the
Regulatory Flexibility Act (RFA) (5
U.S.C. 601 et seq.); to consider
voluntary consensus standards pursuant
to section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (NTTAA) (15 U.S.C. 272
note); to consider environmental health
or safety effects on children pursuant to
Executive Order 13045, entitled
‘‘Protection of Children from
Environmental Health Risks and Safety
Risks’’ (62 FR 19885, April 23, 1997); or
to consider human health or
environmental effects on minority or
low-income populations pursuant to
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
The Agency will consider such
comments during the development of
any subsequent proposed rule as it takes
appropriate steps to address any
applicable requirements.
List of Subjects in 40 CFR Part 799
Environmental protection, Bisphenol
A, BPA, Chemicals, Hazardous
substances, Reporting and
recordkeeping requirements.
PO 00000
Frm 00045
Fmt 4702
Sfmt 4702
44547
Dated: July 20, 2011.
Stephen. A. Owens,
Assistant Administrator, Office of Chemical
Safety and Pollution Prevention.
[FR Doc. 2011–18842 Filed 7–25–11; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
50 CFR Part 17
[Docket No. FWS–R1–ES–2010–0023; MO
92210–0–008–B2]
Endangered and Threatened Wildlife
and Plants; 12-Month Finding on a
Petition To List the Giant Palouse
Earthworm (Drilolerius americanus) as
Threatened or Endangered
Fish and Wildlife Service,
Interior.
ACTION: Notice of 12-month petition
finding.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), announce a
12-month finding on a petition to list
the giant Palouse earthworm (Driloleirus
americanus) as threatened or
endangered as petitioned, and to
designate critical habitat under the
Endangered Species Act of 1973, as
amended (Act). After review of all
available scientific and commercial
information, we find that listing the
giant Palouse earthworm is not
warranted at this time. However, we ask
the public to submit to us any new
information that becomes available
concerning the threats to the giant
Palouse earthworm or its habitat at any
time.
DATES: The finding announced in this
document was made on July 26, 2011.
ADDRESSES: This finding is available on
the Internet at https://
www.regulations.gov at Docket Number
FWS–R1–ES–2010–0023. Supporting
documentation we used in preparing
this finding is available for public
inspection, by appointment, during
normal business hours at the U.S. Fish
and Wildlife Service, Washington Fish
and Wildlife Office, 510 Desmond Drive
SE., Suite 102, Lacey, WA 98503–1263;
telephone 360–753–9440; facsimile
360–753–9008. Please submit any new
information, materials, comments, or
questions concerning this finding to the
above street address.
FOR FURTHER INFORMATION CONTACT: Ken
Berg, Manager, Washington Fish and
Wildlife Office (see ADDRESSES). If you
use a telecommunications device for the
deaf (TDD), please call the Federal
SUMMARY:
E:\FR\FM\26JYP1.SGM
26JYP1
Agencies
[Federal Register Volume 76, Number 143 (Tuesday, July 26, 2011)]
[Proposed Rules]
[Pages 44535-44547]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18842]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 799
[EPA-HQ-OPPT-2010-0812; FRL-8880-3]
RIN 2070-AJ83
Testing of Bisphenol A
AGENCY: Environmental Protection Agency (EPA).
ACTION: Advance notice of proposed rulemaking (ANPRM).
-----------------------------------------------------------------------
SUMMARY: Bisphenol A (BPA) (Chemical Abstracts Service Registry Number
(CASRN) 80-05-7), a high production volume (HPV) chemical, is a
reproductive, developmental, and systemic toxicant in animal studies
and is weakly estrogenic. EPA is providing this ANPRM to request
comment on requiring toxicity testing to determine the potential for
BPA to cause adverse effects, including endocrine-related effects, in
environmental organisms at low concentrations. EPA is also seeking
comment on requiring environmental testing consisting of sampling and
monitoring for BPA in surface water, ground water, drinking water,
soil, sediment, sludge, and landfill leachate
[[Page 44536]]
in the vicinity of expected BPA releases to determine whether
environmental organisms may currently be exposed to concentrations of
BPA in the environment that are at or above levels of concern for
adverse effects, including endocrine-related effects. This ANPRM is
directed only toward the environmental presence and environmental
effects of BPA. EPA is working with the Department of Health and Human
Services (HHS) on potential human health issues, but is not considering
any additional testing specifically in regard to human health issues at
this time.
DATES: Comments must be received on or before September 26, 2011.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2010-0812, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Document Control Office (7407M), Office of Pollution
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001.
Hand Delivery: OPPT Document Control Office (DCO), EPA
East Bldg., Rm. 6428, 1201 Constitution Ave., NW., Washington, DC.
Attention: Docket ID Number EPA-HQ-OPPT-2010-0812. The DCO is open from
8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The
telephone number for the DCO is (202) 564-8930. Such deliveries are
only accepted during the DCO's normal hours of operation, and special
arrangements should be made for deliveries of boxed information.
Instructions: Direct your comments to docket ID number EPA-HQ-OPPT-
2010-0812. EPA's policy is that all comments received will be included
in the docket without change and may be made available on-line at
https://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov Web site is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
Docket: All documents in the docket are listed in the docket index
available at https://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, will be publicly available only
in hard copy. Publicly available docket materials are available
electronically at https://www.regulations.gov, or, if only available in
hard copy, at the OPPT Docket. The OPPT Docket is located in the EPA
Docket Center (EPA/DC) at Rm. 3334, EPA West Bldg., 1301 Constitution
Ave., NW., Washington, DC. The EPA/DC Public Reading Room hours of
operation are 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding
legal holidays. The telephone number of the EPA/DC Public Reading Room
is (202) 566-1744, and the telephone number for the OPPT Docket is
(202) 566-0280. Docket visitors are required to show photographic
identification, pass through a metal detector, and sign the EPA visitor
log. All visitor bags are processed through an X-ray machine and
subject to search. Visitors will be provided an EPA/DC badge that must
be visible at all times in the building and returned upon departure.
FOR FURTHER INFORMATION CONTACT: For technical information contact:
Mary Dominiak, Chemical Control Division (7405M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202) 564-8104; e-mail address: dominiak.mary@epa.gov.
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; e-mail address: TSCA-Hotline@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you manufacture
(defined by statute to include import) or process BPA (CASRN 80-05-7).
BPA is listed on the Toxic Substances Control Act (TSCA) Chemical
Substance Inventory (TSCA Inventory) under the name phenol, 4,4'-(1-
methylethylidene)bis-. Potentially affected entities may include, but
are not limited to:
Chemical manufacturers (including importers) (NAICS codes
325, 32411), e.g., chemical manufacturing and petroleum refineries of
BPA.
Plastics material and resin manufacturers (NAICS code
325211), e.g., manufacturers and processors of BPA-based polycarbonate
plastics and epoxy resins.
Foundries (NAICS codes 331512, 331524, 331528), e.g.,
steel investment foundries, aluminum foundries, and other non-ferrous
foundries, except die-casting, using BPA in casting sands.
Paint and coating manufacturers (NAICS code 325510), e.g.,
manufacturers of epoxy-based paints and other coating products that may
contain BPA.
Paper recyclers (NAICS codes 322110, 322121, 3222), e.g.,
pulp mills, paper (except newsprint) mills, and converted paper product
manufacturers that may process waste thermal paper containing BPA.
Materials recovery facilities (NAICS code 562920), e.g.,
facilities separating and sorting recyclable materials that may handle
thermal paper, polycarbonates, or food and beverage cans lined with
BPA-based epoxy coatings.
Custom compounders of purchased resins (NAICS code
325991), e.g., facilities where resins are made from recycled
polycarbonate plastics that may contain BPA.
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the technical person listed under FOR FURTHER
INFORMATION CONTACT.
[[Page 44537]]
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When submitting comments,
remember to:
i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
iv. Describe any assumptions and provide any technical information
and/or data that you used.
v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
viii. Make sure to submit your comments by the comment period
deadline identified.
II. Background
A. What action is the agency taking?
As a follow-up to the BPA Action Plan released on March 29, 2010
(Ref. 1), EPA is issuing this ANPRM under TSCA section 4(a) (15 U.S.C.
2603(a)) to solicit public input on the necessity for and best approach
to obtain environmental effects, exposure, and pathway information
relevant to a determination that BPA either does or does not present an
unreasonable risk of injury to the environment. In particular, EPA
requests comment on:
1. Whether EPA should propose requiring specific toxicity testing
to more fully characterize the effects of BPA on environmental
organisms at low concentrations.
2. Whether EPA should propose requiring environmental testing
consisting of sampling and monitoring, particularly in the vicinity of
reported releases of BPA into the environment, and what design and
protocol it should use for such sampling and monitoring, in order to
identify potential sources and pathways of exposure and determine the
extent to which environmental organisms may be exposed to BPA
concentrations of concern as determined by existing data and by
additional studies that are either already underway or would be
conducted under a test rule.
3. EPA additionally requests comment and supporting information
regarding which TSCA section 4(a)(1) finding authority would be most
appropriate for the purpose of a BPA test rule proposal, as discussed
in Unit II.C. Any proposal would ultimately be based on EPA's
assessment of the relevant information available at the time of
proposal.
B. What testing is EPA considering in this ANPRM?
In this ANPRM, EPA is considering requiring both toxicity testing
for environmental organisms exposed to BPA and environmental testing
consisting of sampling and monitoring in the vicinity of reported BPA
releases to measure its environmental presence. The toxicity testing is
being considered to resolve existing uncertainties concerning the
potential for BPA to elicit adverse effects in ecologically relevant
species, including endocrine-related impacts that could occur at low
doses. The environmental testing is being considered to resolve
existing uncertainties concerning potential sources of and pathways
leading to environmental exposures and to determine whether or not the
concentrations to which organisms currently may be exposed in the
environment are at or above levels of concern for adverse effects,
including endocrine-related effects.
On May 17, 1985, EPA published in the Federal Register a proposed
rule (50 FR 20691) to require human health and environmental testing in
response to the TSCA Interagency Testing Committee's (ITC) 14th report
published in the Federal Register issue of May 29, 1984 (49 FR 22389),
which designated BPA for priority consideration for health and
environmental effects. EPA proposed standard freshwater and marine
acute fish and aquatic invertebrate toxicity tests, and freshwater
aquatic plant toxicity tests. Test results were submitted in response
to the proposal for freshwater and marine acute fish, acute aquatic
invertebrate, and algal toxicity. EPA's final rule published in the
Federal Register issue of September 18, 1986 (51 FR 33047) (1986 Final
Rule), terminated the test rule process for environmental effects
testing for BPA. At the time, EPA determined that the test data were
adequate and that chronic freshwater organism testing was not needed
because the LC50 values for the standard acute aquatic
organism toxicity tests were greater than 1.0 parts per million (ppm)
(1 milligram/Liter (mg/L)), and the ratios of 48-hour to 96-hour
LC50 values were not greater than 2. Since the 1986 Final
Rule, however, several studies on BPA have raised concerns about its
environmental effects at concentrations less than 1.0 ppm (1 mg/L).
As stated in the BPA Action Plan (Ref. 1), EPA does not intend to
initiate regulatory action under TSCA at this time on the basis of
human health. EPA remains committed to protecting human health, but
notes that most human exposure, including exposure to children, comes
through food packaging materials under the jurisdiction of the Food and
Drug Administration (FDA) in HHS. FDA, together with the Centers for
Disease Control and Prevention (CDC) and the National Institute of
Environmental Health Sciences (NIEHS), is investing in important new
health studies in both animals and humans to better determine and
evaluate the potential health consequences of BPA exposures. EPA will
continue to coordinate closely with FDA, CDC, and NIEHS on this
activity. To the extent that FDA may identify health concerns from BPA
in food contact materials, EPA will work with FDA to identify and
assess potential substitutes. Levels of exposure that may be identified
by the ongoing review as being of concern to human health, including
children's health, will affect the extent to which EPA would take
additional action to address potential risks to human health resulting
from uses within TSCA jurisdiction.
1. What is currently known about the environmental hazard of BPA?
The toxicity of BPA has been studied extensively, as indicated in the
multiple studies cited in the BPA Action Plan (Ref. 1).\1\ There is
general agreement
[[Page 44538]]
among multiple reviewers, including government regulatory agencies in
the United States, Japan, the European Union (EU), and Canada, that BPA
is a reproductive and developmental toxicant at doses in animal studies
of [gteqt] 50 mg/kilogram-body weight (kg-bw)/day (delayed puberty in
male and female rats and male mice; discussed in Refs. 2-9); [gteqt]
235 mg/kg-bw/day (reduced fetal or birth weight or growth early in
life, effects on testis of male rats; Ref. 9); and [gteqt] 500 mg/kg-
bw/day (possible decreased fertility in mice, altered estrous cycling
in female rats, and reduced survival of fetuses; Ref. 9). Systemic
effects (reduction in body weight, changes in relative organ weights,
and increases in liver toxicity; Refs. 2-8) were observed at doses
above 5 mg/kg-bw/day (identified as a no observed adverse effect level
(NOAEL); lowest observed adverse effect level (LOAEL) of 50 mg/kg-bw/
day). There are reports of endocrine-related low-dose effects on
puberty and neurological development (brain, behavior; Ref. 9) at doses
in animal studies as low as 2 microgram ([mu]g)/kg-bw/day. There is
disagreement in the scientific community at large about whether effects
seen at doses in animals less than 1 mg/kg/day are meaningful and
relevant to humans. FDA, together with NIEHS and CDC, are engaging in
additional research to better determine and evaluate the potential
human health consequences of exposures to BPA, including exposures at
low doses (Ref. 10). EPA is working with FDA, NIEHS, and CDC on this
ongoing research, and is not considering any additional testing
specifically in regard to human health issues at this time.
---------------------------------------------------------------------------
\1\ EPA's response to the request for correction of the
information provided in the Action Plan that was filed under the
``Agency's Information Quality Guidelines'' by the American
Chemistry Council is available at https://www.epa.gov/quality/informationguidelines/iqg-list.html.
---------------------------------------------------------------------------
Many studies have been conducted to determine potential effects of
BPA exposure on invertebrates, fish, amphibians, reptiles, birds, and
wild mammals, and a review is provided by Crain et al. (Ref. 11). In
general, studies have shown that BPA can affect growth, reproduction,
and development in aquatic organisms. Evidence of sub-lethal effects
mediated through either endocrine or non-endocrine related mechanisms
in fish, amphibians, reptiles, and invertebrate aquatic organisms has
been reported at potentially environmentally relevant exposure levels
lower than those required for acute toxicity. There is a widespread
variation in reported values for these sub-lethal effects, but many
fall in the range of 1 [micro]g/L to 1 mg/L (Ref. 6; also, see
individual studies noted in Table 2 of Unit II.B.2.).
The ecological hazard for BPA has been evaluated in three different
risk assessments performed by the EU, Canada, and Japan (Refs. 7, 6,
and 8), as summarized in Table 1 of this unit. The different
methodologies, endpoints, and study results used by each country to
derive their ecological values highlight the significant uncertainty in
the estimated hazard values. Japan concluded that ``the current
exposure levels of BPA will not pose unacceptable risks to the local
populations of aquatic life, particularly fish'' (Ref. 8). In contrast,
the EU concluded that although the predicted exposure concentrations
were significantly below its hazard values, there was a need for
further information and/or testing on such organisms as freshwater
snails (Ref. 7).
Canada used a study (Ref. 12) that reported reduced sperm quality
and delayed ovulation in brown trout at a very low concentration in
water (1.75 [micro]g/L). Other effects such as the induction of
intersex (or testes-ova in males and females), decreased
spermatogenesis, induction of vitellogenin, delayed or ceased
ovulation, or histological liver changes were also reported in other
studies referenced in the EU and Japanese hazard evaluations. However,
because there were no standardized test guidelines or risk assessment
guidance for evaluating some of these endocrine-related effects at the
time of these assessments, the EU and Japan set ecotoxicological hazard
values based on conventional effects (mortality and reproductive
effects) from standardized studies. In contrast, Canada concluded in
its hazard characterization that:
[c]onsidered together, the data provide strong evidence that
bisphenol A is capable of eliciting adverse effects: (1) following
prolonged exposure at levels below those usually seen to elicit
effects in standard toxicity tests (i.e., tests based on recognized
methods which evaluate endpoints such as survival, reproduction and
growth); (2) following brief low-dose exposure, particularly at
sensitive developmental stages, with effects apparent later in the
life cycle; (3) on filial generations following parental exposure;
and (4) using more than one mode of action.
(Ref. 6)
Canada concluded that BPA concentrations in water have the
potential to cause adverse effects on populations of pelagic organisms
in Canada and concentrations in biota have the potential to cause
adverse effects in populations of wildlife in Canada, but that there is
a low risk of direct adverse effects to sediment organisms and to avian
wildlife species in Canada. In the conclusion of its risk assessment,
Canada stated that it is considered appropriate to apply a
precautionary approach when characterizing risk, observing ``it is
concluded that bisphenol A is entering the environment in a quantity or
concentration or under conditions that have or may have an immediate or
long-term harmful effect on the environment or its biological
diversity'' (Ref. 6).
Table 1--Summary of Bisphenol A Ecological Values
----------------------------------------------------------------------------------------------------------------
Predicted no effect
concentrations
Country (microgram/Liter Endpoints
([mu]g/L)) \1\
----------------------------------------------------------------------------------------------------------------
European Union.............................. 1.5 The predicted no effect concentration (PNEC)
for aquatic organisms (derived by using a
statistical analysis of data from available
data on freshwater and marine aquatic
organisms (in this case, 16 different
studies, unpublished and published, from 10
different taxonomic groups)) to arrive at a
value of 7.5 [mu]g/L, which is divided by an
uncertainty factor of 5, resulting in a PNEC
of 1.5 [mu]g/L (Ref. 7).
Canada...................................... 0.175 This PNEC was derived by using a lowest
observed effect concentration (LOEC) of 1.75
[mu]g/L for reduced semen quality and
delayed ovulation in a brown trout study
(Lahnsteiner et al. 2005) and applying an
uncertainty factor of 10 (Ref. 6).
[[Page 44539]]
Japan....................................... 1.6 The PNEC was derived by using the 16 [mu]g/L
no effect concentration (NOEC) for egg
hatchability in fathead minnows from the
unpublished 3-generation study by Sumpter,
et al. (2001) multi-generation fish study
and dividing by an uncertainty factor of 10
(Ref. 8).
----------------------------------------------------------------------------------------------------------------
\1\ In the European Union, Canada, and Japan, a predicted no effect concentration (PNEC) is compared directly
with an exposure value to evaluate risk. If the ratio of environmental concentration to PNEC is less than one,
the risk is generally considered acceptable. As noted in the table, countries use different approaches for
generating PNECs, and the precise values may differ even when based on the same studies.
EPA considers that the uncertainty demonstrated by these divergent
opinions concerning interpretation of the results of existing
environmental toxicity studies, particularly studies addressing
potential effects at low levels of exposure, may indicate further
testing is necessary to resolve the question of whether or not BPA
presents an unreasonable risk of injury to the environment on the basis
of those effects. This is due to the combination of the existence of
measured values, as discussed in Unit II.B.4. and as shown in that
unit's Table 3, for BPA in U.S. surface waters at a mean-concentration
range of up to 1.78 [mu]g/L (parts per billion (ppb)) and a single-
maximum concentration of 12 [mu]g/L (ppb); in ground water at a mean-
concentration range of up to 1.9 [mu]g/L (ppb) and a maximum
concentration of 2.55 [mu]g/L (ppb); and in freshwater sediments at a
median concentration of 0.6 [mu]g/kg (ppb) dry weight and a maximum
concentration of 140 [mu]g/kg (ppb) (see Table 3 in Unit II.B.4.), and
the existence of many hazard studies describing a variety of effects in
aquatic organisms at some of these concentrations (see Table 2 in Unit
II.B.2.), leaving little or no room for a reasonable or acceptable
margin of exposure.
In order to assess the potential for BPA to harm the environment in
the United States, EPA considers it important to address two basic
areas of inquiry relevant to identifying the hazard and exposure
components of a risk analysis:
a. What additional hazard information is needed to fully
characterize the effects of BPA in environmental organisms at low doses
and potentially environmentally relevant concentrations?
b. What levels of BPA are present in the environment, particularly
in areas where environmental exposures are likely to be highest (e.g.,
near BPA manufacturing facilities, polycarbonate and epoxy resin
manufacturing and processing facilities, foundries, landfills,
wastewater treatment plants (WWTPs), and other locations associated
with uses and/or releases of BPA)?
2. What additional hazard information is needed on the effects of
BPA on environmental organisms? EPA performed a literature search to
identify relevant scientific information to assess the acute and
chronic toxicity of BPA to environmental organisms from 2007 \2\ to the
present. A total of 468 articles were found (Ref. 13), of which 30 were
found to be of some relevance (Ref. 14). Since thorough analyses of
acute and chronic toxicity for ``conventional endpoints'' (which
generally address immediate effects on survival or reproduction) had
already been conducted for BPA by Canada, the EU, and Japan (Refs. 6-
8), EPA performed a more detailed evaluation of the scientific
literature for sub-lethal effects at lower concentrations (< 100 [mu]g/
L). These sub-lethal effects in both vertebrates and invertebrates
could be mediated either through endocrine or non-endocrine-related
mechanisms. There are many studies indicating such sub-lethal effects
from BPA exposures at levels that, based on the information discussed
in Unit II.B.4., appear to be potentially environmentally relevant
concentrations because they may occur in the environment. Some of these
studies are included in Table 2 of this unit.
---------------------------------------------------------------------------
\2\ The starting date of 2007 was used to allow for some overlap
between the thorough searches done by Canada, the EU, and Japan.
Table 2--Summary of Reported Hazard Effects of Bisphenol A at Potentially Environmentally Relevant
Concentrations
----------------------------------------------------------------------------------------------------------------
Effect concentrations
Test organism Endpoint (microgram/Liter References (Listed in
([mu]g/L)) Ref. 14)
----------------------------------------------------------------------------------------------------------------
Amphibians:
Xenopus laevis (African clawed Inhibited metamorphosis via 22.8.................. Heimeier et al., 2009.
frog). T3 pathways.
Xenopus laevis................. High ratio of females to 23.................... Levy et al., 2004.
males--1st study.
Xenopus laevis................. High ratio of females to only at 23............ Levy et al., 2004.
males--2nd study.
Avian:
Gallus domesticus (chicken).... Delayed development of 2..................... Furuya et al., 2006.
wattle, comb, and testes.
Gallus domesticus.............. Inhibited development of 20.................... Furuya et al., 2006.
seminiferous tubuli and
spermatogenesis.
Fish:
Dicentrarchus labrax (seabass). Increased vitellogenin 10.................... Correia et al., 2007.
production.
[[Page 44540]]
Misgurnus anguillicaudatus Increased vitellogenin 10.................... Lv et al., 2007.
(Chinese loach). production.
Orizias latipes (medaka)....... Egg hatchability delayed... 13 only............... Yokota et al., 2000.
Orizias latipes................ Loss of testicular 50.................... Metcalfe et al., 2001.
structure, increased
fibrotic tissue; decreased
sperm cells.
Orizias latipes................ Vitellogenin production.... 10.................... Kashiwada et al.,
2002.
Orizias latipes................ Increased female proteins 10.................... Tabata et al., 2001.
(i.e., vitellogenin).
Orizias latipes................ Decreased egg hatching in 2 only................ Japanese Ministry of
2nd generation. the Environment,
2006.
Orizias latipes................ Increased male 49.7.................. Japanese Ministry of
hepatosomatic index. the Environment,
2006.
Pimephales promelas (fathead Increased vitellogenin 52.8.................. Rhodes et al., 2007
minnow). production. (unpublished).
Xiphophorus helleri (swordtail Reduced sword tail length.. 20.................... Kwak et al., 2001.
fish).
Cyprinus carpio (carp)......... Oviduct formation in males. 32.................... Bowmer & Gimeno, 2001
(unpublished).
Cyprinus carpio................ Altered sex steroid levels; 1..................... Mandich et al., 2007.
alterations in testes
structure; oocyte atresia.
Invertebrates:
Bellamya purificata (snail).... Enzyme activities in gills 1..................... Li et al., 2008.
and digestive glands.
Marisa cornuarietis (ramshorn Superfeminization.......... 1..................... Oehlmann et al., 2000.
snail).
Marisa cornuarietis............ Increased egg and clutch 0.25 at 20 [deg]C..... Oehlmann et al., 2006.
production per female.
Marisa cornuarietis............ Increased egg production... 0.25 at 27 [deg]C..... Oehlmann et al., 2006.
Marisa cornuarietis............ Increased clutch production 5 at 27 [deg]C........ Oehlmann et al., 2006.
Potamopyrgus antipodarum Increased growth/embryo 5 only................ Jobling et al., 2004.
(snail). production.
Potamopyrgus antipodarum....... Unshelled embryos.......... 30.................... Duft et al., 2003.
Potamopyrgus antipodarum....... Increased embryo production 1..................... Duft et al., 2003.
Nucella lapillus (marine snail) Superfeminization; reduced 1..................... Oehlmann et al., 2000.
sperm/penis length/
prostrate gland in males.
Acartia tonsa (copepod)........ Increased egg production... 20 (day 10 only)...... Andersen et al., 1999.
Tigriopus japonicus (intertidal Delayed development 0.1................... Marcial et al., 2003.
copepod). (Parent).
Tigriopus japonicus............ Delayed development (F1)... 0.01.................. Marcial et al., 2003.
Chironomus riparius............ Delayed emergence (2nd 0.078................. Watts et al., 2001.
generation).
Chironomus riparius............ Mouthpart deformities...... 0.01.................. Watts et al., 2003.
----------------------------------------------------------------------------------------------------------------
There is debate in the scientific literature on how best to
interpret these low-dose, sub-lethal effects of BPA and other chemicals
on environmental organisms. EPA is concerned that these sub-lethal
effects may be having a detrimental effect on populations of aquatic
organisms over time based on the reported increased susceptibility of
subsequent generations exposed to BPA in multi-generation invertebrate
and fish studies. For example, in the intertidal copepod (Tigriopus
japonicus), delayed development was reported in the first generation at
0.1 [micro]g/L, but at a 10-fold lower concentration of 0.01 [micro]g/L
in the next generation (Ref. 15). In the freshwater midge (Chironomus
riparius), the first generation did not have a significant delay in
emergence time from the egg, but in the second generation emergence was
delayed at 0.08 [micro]g/L (Ref. 16). Egg hatchability decreased in
fathead minnows (Pimephales promelas) at 640 [micro]g/L in the first
(F1) generation, then at 160 [micro]g/L in the second (F2) generation
(Ref. 17). Although the mechanisms of action leading to effects may be
different for vertebrate and invertebrate organisms, this suggests the
potential for increasing developmental and reproductive effects in
populations of aquatic organisms that have repeated exposures to BPA
for generations, even at very low concentrations.
Testing with BPA has been extensive at sub-lethal concentrations,
but the studies with effects across multiple species generally have
flaws associated with them, including lack of analytical monitoring,
small sample size, inadequate replication, or use of inappropriate
statistical analyses leading to incorrect conclusions of study results.
Studies in ramshorn snails, for example, resulted in superfeminization
(e.g., the formation of additional female organs, enlarged accessory
sex glands, gross malformations of the pallial oviduct, and a
stimulation of egg and clutch production) at very low concentrations in
one lab (Ref. 18), but those results were not found in studies by other
researchers (Refs. 19-21).
In addition, in some studies, BPA demonstrated effects at very low
concentrations, but no effects were observed at the higher test
concentrations. For example, tadpoles exposed to 2.3, 23, and 230
[micro]g/L of BPA (Ref. 22) before metamorphosis had an increased
female to male ratio at 23 [micro]g/L only. These types of anomalous
responses have been reported across multiple species of fish and
invertebrates for BPA and are characteristic of endocrine-active
[[Page 44541]]
chemicals. They suggest inhibition of reproduction and development at
low concentrations and overcompensation by the organism at higher
concentrations in response to a toxicant (Ref. 23).
It is difficult to interpret this information in a regulatory
context, because the scientific methods employed in individual academic
settings to test a hypothesis are not necessarily geared toward meeting
or establishing generally applicable guidelines for evaluating
ecotoxicity and setting corresponding regulatory limits or controls. In
terms of environmental toxicity, EPA considers the currently available
research as evidence that BPA has the potential to interact with the
estrogen hormone system. There is some evidence that BPA is also active
via the thyroid hormone pathway in amphibians and fish (Refs. 24 and
25). More recent evidence indicates that BPA also acts as an androgen
receptor antagonist in both mammals and fish (Ref. 26). There are
currently efforts underway by EPA's Office of Science Coordination and
Policy (OSCP) through the Endocrine Disruptor Screening Program (EDSP)
and the Organization for Economic Cooperation and Development (OECD)
Endocrine Disrupter Testing and Assessment Work Group (EDTAWG), among
others, to determine the best approach to evaluate and assess such
effects (Refs. 27-29).
EPA is inviting comment on the need to further determine the hazard
of BPA to various ecological species. The purpose of further testing
would be to produce high quality data that could be used for risk
assessment purposes for any adverse reproductive or developmental
effects in different species that might result from the interactions
identified through the available research.
3. What are the issues for comment concerning toxicity testing? EPA
invites comment on whether and what testing should be required to
further describe the hazard of BPA to various ecological species to
resolve the low dose effects issue. EPA particularly invites comment on
the following, for which little or no clarifying hazard information
appears to be currently available or for which much of the available
data have been derived from studies of questionable quality or
uncertain interpretation:
a. Effects of BPA on fish in long-term tests, including those that
encompass multiple generations.
b. Effects of BPA on amphibians at sensitive life stages,
specifically metamorphosis (thyroid effects) and sexual development/
differentiation (hypothalamic-pituitary-gonadal axis effects).
c. Effects of BPA on birds over multiple generations.
d. Effects of BPA on aquatic invertebrate species.
EPA further invites comment on the availability of current test
guidelines that could help address these issues. This may include, for
example, considering the draft recommendations concerning aquatic life
criteria for contaminants of emerging concern (Ref. 30). Additionally,
EPA is inviting the public to describe and define where they believe
there are data gaps concerning the environmental toxicity of BPA,
especially at low concentrations, or whether and on what basis they
believe the current data are sufficient to determine whether BPA does
or does not present an unreasonable risk of injury to the environment.
4. What levels of BPA are present in the U.S. environment? BPA is
present in the environment as a result of direct releases from
manufacturing or processing facilities (Ref. 31). BPA also may be
present in the environment as a result of fugitive emissions during
processing and handling, release of unreacted monomer from products
(Ref. 9), or possibly from degradation of products under certain
conditions. In addition, although no environmental studies on thermal
paper have been done in the United States, based on information from
EPA's review of European and Japanese studies, the use of unconjugated
BPA in thermal paper also may contribute to environmental releases of
BPA from paper manufacturing and recycling plants and to the presence
of BPA in the stream of recycled paper used in toilet paper, paper
tableware, and other products, and may contribute to the presence of
BPA in landfills because paper products are a major contributor to the
U.S. solid waste stream (Refs. 7, 32-36).\3\
---------------------------------------------------------------------------
\3\ Recent studies also indicate thermal paper may contribute
directly to human exposure to BPA through dermal contact. In one
U.S. study, for example, pregnant women who worked as cashiers, who
presumably had frequent contact with thermal paper used in cash
register receipts, had the highest urinary BPA concentrations
compared with pregnant women in other occupations (Ref. 37).
---------------------------------------------------------------------------
Significant research has been done to document widespread human
population exposures to BPA in the United States using biomonitoring
(Refs. 37-41). Although these studies and reports indicate that most
people in the United States have measurable levels of BPA in their
bodies, these data do not identify the relative source contributions to
BPA exposure. Researchers generally accept that food contact uses of
materials containing BPA, such as polycarbonate bottles or epoxy
linings in food and beverage cans, are a likely major source of human
exposure, but the relative contributions of food contact uses,
potential TSCA uses, or other environmental sources cannot be
extrapolated reliably from these existing data. For information about
the multi-agency effort to evaluate the potential human health
consequences of BPA exposures, see the discussion in Unit II.B.
According to the Toxics Release Inventory (TRI) Database, total
release of BPA in the United States in 2007 was 1,132,062 pounds (lbs),
with releases of 122,965 lbs to air, 6,246 lbs to water, 14,972 lbs
released on-site to land, and 684,638 lbs transferred off-site to land.
An additional 32,928 lbs were reported as off-site water transfer to
Publicly Owned Treatment Works (POTWs), with another 2,759,705 lbs
transferred to incineration (Ref. 31).
Some information is available for BPA concentrations in U.S. water
and other environmental media (see Table 3 in Unit II.B.4., providing
values from the U.S. studies cited in this discussion). Most
environmental monitoring results show that the concentrations of BPA in
surface water bodies are lower than 1 [mu]g/L (ppb), mainly due to its
partitioning and biodegradability properties (Ref. 42). BPA was
detected at a median concentration of 0.14 [mu]g/L (ppb) and a maximum
concentration of 12 [mu]g/L (ppb) in 41.2% of 85 samples collected from
U.S. streams in 1999 and 2000 (Ref. 43). The maximum concentration of
12 [mu]g/L (ppb) was much higher than any of the other samples reported
in the study; the next highest concentration reported was 5.2 [mu]g/L
(ppb), and as indicated by the median concentration of 0.14 [mu]g/L
(ppb), BPA concentration in other U.S. waters was much lower. A recent
review of reports of BPA in surface water found that BPA was reported
in 26 studies in North America (2 in Canada and 24 in the United
States) with detection in 80% (852 of 1,068) of surface water samples.
The median concentration reported was 0.081 [micro]g/L (ppb) and the
95th percentile concentration was 0.47 [micro]g/L (ppb) (Ref. 44).
Two studies have addressed individual WWTPs in two different parts
of the United States. In 2001 and 2002, BPA was not detected above the
detection limit of 0.0001 [mu]g/L (ppb) in Louisiana in effluent from a
WWTP, in samples collected from surface waters in Louisiana, or in
drinking water at various stages of treatment at plants in Louisiana
(Ref. 45). A 2008 study
[[Page 44542]]
sampled BPA in treated wastewater from the East Bay Municipal Utilities
WWTP in Oakland, California, and in a variety of locations that
discharge to this WWTP (Ref. 46). This study reported detecting (limit
of detection = 0.25 [micro]g/L (ppb)) BPA in two of three treated
wastewater samples at 0.38 and 0.31 [micro]g/L (ppb). It also reported
detecting BPA in wastewater generated by a pharmaceutical manufacturer
(0.295 [micro]g/L (ppb)), an industrial laundry (21.5 [micro]g/L
(ppb)), and a paper products manufacturer (0.753 [micro]g/L (ppb)).
While U.S. studies on wastewater are limited to only two State
locations, a Canadian study published in 2000 reported BPA
concentrations ranging from 49.9 to 0.031 [micro]g/L (ppb) in sewage
influent and effluent (generally < 1 [micro]g/L (ppb) in the influent
and < 0.3 [micro]g/L (ppb) in the effluent) and from 36.7 to 0.104
[micro]g/g (ppm) in raw and digested sewage sludge from multiple WWTPs
in Canada (Ref. 47). The same authors reported that BPA contamination
was detected in 100% of sewage samples from 31 WWTPs across Canada with
concentrations ranging from 0.080 to 4.98 [micro]g/L (ppb) (median
0.329 [micro]g/L (ppb)) for the influent and from 0.010 to 1.08
[micro]g/L (ppb)(median 0.136 [micro]g/L (ppb)) for the effluent (Ref.
48). Based on comparison of influent and effluent levels, they
estimated that BPA in the influent was removed by the sewage treatment
process with a median reduction rate of 68%. BPA was detected in sludge
samples at concentrations ranging from 0.033 to 36.7 [micro]g/g (ppm),
on a dry weight basis. The authors also reported a wide range of BPA in
wastewater discharges from industrial facilities in the Toronto,
Canada, area, with concentrations ranging from 0.23 to 149.2 [micro]g/L
(ppb). Higher BPA levels in wastewater were associated with facilities
producing chemicals and chemical products and packaging and paper
products, and with commercial dry cleaning establishments. BPA
concentrations in pulp and paper mill sludge ranged from < 0.02 (below
detection limit) to 3.33 [micro]g/g (ppm), with a median value of 0.076
[micro]g/g (ppm), on a dry weight basis (Ref. 48). EPA notes that U.S.
wastewater treatment conditions and industrial and commercial
discharges may differ from what was found in Canada, but considers this
Canadian study to be informative.
Municipal wastewater treatment produces solid byproducts, commonly
referred to as sewage sludge. After additional treatment to meet
regulatory standards for pathogen, nutrient, and metal content, this
treated sewage sludge, now classified as biosolids, may be disposed of
by land application; biosolids may also be incinerated or disposed of
in landfills. A U.S. study published in 2006 measured BPA in 9 treated
biosolids products from WWTPs in 7 States and found that all contained
between 1,090 and 14,400 [mu]g/kg (ppb) (median 4,690 [mu]g/kg (ppb))
(Ref. 49). A 2008 study reported BPA in treated biosolids from a
municipal U.S. WWTP at 4,600 [mu]g/kg (ppb) and reported 81 [mu]g/kg
(ppb) in soil that received the land-applied biosolids (Ref. 50). That
study detected BPA at 81 [mu]g/kg (ppb) in earthworms living in treated
soil. The authors also reported detecting 147 [mu]g/kg (ppb) in a
nearby ``control'' soil that did not receive treatment with biosolids.
That anomalous result was not explained.
In 2000, the U.S. Geological Survey (USGS) collected samples from
47 ambient ground water sites (not drinking water wells) in 18 States
and analyzed them for 65 organic wastewater contaminants. BPA was
detected in 29.8% of the sampled ground water sites, with a mean
detected concentration of 1.78 [mu]g/L (ppb) and a range of 1.06 to
2.55 [mu]g/L (ppb). BPA was among the top 5 most frequently detected
organic compounds in this study (Refs. 51 and 52).
In the summer of 2001, the USGS collected samples from 74 sources
of raw, untreated, drinking water in 25 States and Puerto Rico, in
areas that were known or suspected to have at least some human and/or
animal wastewater sources in upstream or upgradient areas. These
sources comprise 25 ground water and 49 surface water sources of
drinking water serving populations ranging from one family to more than
8 million people. BPA was detected in 9.5% of these samples at a
reporting level of 1 [mu]g/L (ppb). The maximum concentration measured
in these samples was 1.9 [mu]g/L (ppb) (Refs. 51 and 53).
Landfill leachate from one U.S. study reported maximum BPA
concentrations of 1.7 [mu]g/L (ppb) in landfill leachate and 1.4 [mu]g/
L (ppb) in the receiving ground water plume at a landfill on Cape Cod,
Massachusetts, that was known to be leaking (Ref. 54). Data for other
landfill sites in the United States were not available, and this single
point is not representative of the country. Landfill leachate from
other countries contained more than 500 [mu]g/L (ppb) of BPA (Ref. 42).
Studies conducted at Japanese landfills resulted in maximum untreated
leachate concentrations of 17,200 [mu]g/L (ppb) and treated leachate
concentrations of 5.1 [mu]g/L (ppb) (Ref. 11).
Wilson et al. (Ref. 55) reported that BPA concentrations in soil
samples taken from outdoor play areas of homes and daycare centers
ranged from 4-14 ppb dry weight, with means of 6-7 ppb dry weight.
Klecka et al. (Ref. 44) reported a median concentration of 0.6 ppb BPA
in North American freshwater sediments, including non-detected samples;
BPA concentrations in samples from the United States ranged from 1.4 to
140 ppb dry weight. Levels in U.S. marine sediments were reported to
have a median of 3.5 ppb of BPA and to range from 1.5 to 5 ppb dry
weight (Ref. 56).
Table 3--U.S. Reported Environmental Concentrations of Bisphenol A
----------------------------------------------------------------------------------------------------------------
Mean or range of means
Location (parts per billion Range (ppb) References
(ppb))
----------------------------------------------------------------------------------------------------------------
Surface Water...................... <0.0001 to 0.14*...... <0.0001 to 12......... Barnes et al., 2008a (Ref.
51).
Boyd et al., 2003 (Ref.
45).
Boyd et al., 2004 (Ref.
57).
Focazio et al., 2008 (Ref.
53).
Klecka et al., 2009 (Ref.
44).
Kolpin et al., 2002 (Ref.
43).
Staples et al., 2000 (Ref.
58).
Zhang et al., 2007 (Ref.
59).
Ground Water....................... NR** to 1.78 [dagger]. <0.003 to 2.55........ Barnes et al., 2008a (Ref.
51).
Barnes et al., 2008b (Ref.
52).
Focazio et al., 2008 (Ref.
53).
Rudel et al., 1998 (Ref.
54).
[[Page 44543]]
Drinking Water..................... <0.0001............... <0.0001 to 0.42....... Boyd et al., 2003 (Ref.
45).
Stackelberg et al., 2004
(Ref. 60).
Wastewater......................... <0.0001............... <0.0001 to 25......... Boyd et al., 2003 (Ref.
45).
Drewes et al., 2005 (Ref.
61).
Jackson and Sutton, 2008
(Ref. 46).
Rudel et al., 1998 (Ref.
54)
Tsai, 2006 (Ref. 42).
Soils.............................. 6 to 7................ 4 to 147.............. Kinney et al., 2008 (Ref.
50).
Wilson et al., 2003 (Ref.
55).
Sediment, Fresh.................... 0.6* [dagger][dagger]. 1.4 to 140 Klecka et al., 2009 (Ref.
[dagger][dagger]. 44).
Sediment, Marine................... 3.5*.................. 1.5 to 5.0............ Stuart et al., 2005 (Ref.
56).
Biosolids.......................... 4,600 to 4,690*....... 1,090-14,400.......... Kinney et al., 2006 (Ref.
49).
Kinney et al., 2008 (Ref.
50)
----------------------------------------------------------------------------------------------------------------
* Value is median.
** Not reported (NR).
[dagger] Mean of values above reporting limit (1 ppb).
[dagger][dagger] Median value includes non-detected values below the minimum detection limit, while the reported
range includes only detected values.
Although there is disagreement in interpreting some of the effects
observed in studies performed to date with BPA, as described in Unit
II.B.1. and 2., a comparison of the range of the effect levels observed
in many studies and the predicted no effect concentration (PNEC) values
used in three international regulatory risk assessments (0.175 to 1.6
[mu]g/L, Table 1 of Unit II.B.1.) with measured concentrations in some
U.S. waters and sediments, which included values as high as 12 [mu]g/L
(ppb) (surface water), 2.55 [mu]g/L (ppb) (ground water), and 140 ppb
sediment (freshwater sediment) (Table 2 of Unit II.B.2.), indicate
possible risk of injury to aquatic organisms. The single available
measurement of BPA in leachate from one U.S. landfill site is not
sufficient to represent or characterize the United States as a whole,
and landfill leachate data from other countries suggest that BPA
concentrations in leachate may be significantly higher than
concentrations in surface water bodies. The direct exposure pathway
from wastewater to environmental organisms, along with the widespread
detection of BPA in WWTP sludges, further suggest that land application
of WWTP sludges may be a significant environmental exposure pathway
that needs to be better understood.\4\
---------------------------------------------------------------------------
\4\ EPA's response to the request for correction of the
information provided in the Action Plan that was filed under the
``Agency's Information Quality Guidelines'' by the American
Chemistry Council is available at https://www.epa.gov/quality/informationguidelines/iqg-list.html.
---------------------------------------------------------------------------
Although most currently available environmental monitoring results
show that the concentrations of BPA in U.S. water bodies are lower than
1 [mu]g/L (ppb) (median concentration of 0.14 [mu]g/L (ppb)), these
environmental measurements represent isolated snapshots in time.
Because these results come from a variety of studies designed for very
different purposes and conditions (for example, laboratory analytical
development contrasted with field monitoring), the data are not readily
comparable and cannot be assembled into a nationally or regionally
representative picture. Particularly in light of the corresponding
uncertainties described in Unit II.B.1. and 2., concerning potential
BPA hazards at low doses, the existing data do not allow EPA to
determine how many areas may exceed potential concentrations of
concern, how often or how long such concentrations may be exceeded, or
the sources or pathways leading to BPA presence in the environment from
manufacturing, processing, distribution in commerce, use, or disposal
that may result in human and environmental exposures. EPA considers
that these existing data would not be sufficient to determine whether
or not an unreasonable risk to the environment exists. To help resolve
these uncertainties, EPA is considering requiring that manufacturers
and processors of BPA conduct environmental testing consisting of
targeted sampling and monitoring of surface water, ground water,
sediment, soil, landfill leachate, and drinking water on and adjacent
to their properties, specifically in the vicinity of manufacturing
facilities and such processing facilities as foundries, WWTPs, paper
and plastics recycling facilities, and other sources of BPA releases as
identified through TRI reporting and other information. These test data
could also help guide development of effective risk management actions
if it should be determined that activities involving BPA present an
unreasonable risk of injury to aquatic or other environmental systems.
Fully understanding exposure pathways and in particular the
magnitude, frequency, and duration of exposure could require a
nationwide survey of the occurrence of the chemical in environmental
media associated with production, processing, use, disposal, and
recycling facilities. However, at this time, EPA is proposing that
selected monitoring of a more limited scope be conducted to help
identify the most likely locations of high exposure and the sources and
pathways of exposure, to determine whether BPA may be present in those
locations at concentrations that pose a risk of concern to aquatic or
other systems. Monitoring of aquatic sites and sediments near releases
(effluents and sludge) from manufacturing and processing sites
(including on-site WWTPs) reporting high releases under TRI or
associated with high releases identified from other information, as
well as monitoring of sites that receive runoff from landfills, would
be included.
EPA believes these targeted monitoring data may provide information
relevant both to the characterization of environmental risk and to the
potential focus of future risk management activities such as those
under TSCA section 6, if the data indicate such activities are
warranted. EPA also considers these data would further inform the issue
of potential human exposure levels attributable to sources other than
the direct food
[[Page 44544]]
contact uses believed to be the principal source of human exposure,
which are regulated by the FDA. As noted earlier in Unit II.B., EPA is
working with FDA, NIEHS, and CDC on additional research to better
determine and evaluate the potential human health consequences of
exposures to BPA, including exposures at low doses. Levels of exposure
that may be identified by FDA as being of concern to human health,
including children's health, would affect the extent to which EPA would
take additional action to address potential risks to human health
resulting from uses within TSCA jurisdiction, but EPA is not
considering any additional testing specifically in regard to human
health issues at this time.\5\
---------------------------------------------------------------------------
\5\ EPA notes, however, that information obtained on the
environmental presence of BPA would be relevant to understanding the
environmental component of human exposures.
---------------------------------------------------------------------------
In order to be useful to an investigation of potential
environmental risks posed by BPA, environmental testing must be
representative and of known quality. To accomplish this, data should be
collected using approved or recognized sampling, preparation, and
analytical techniques. Appropriate quality assurance and quality
controls also should be incorporated in the protocols for collection
and analyses.
A further complicating factor in the assessment of potential
environmental risks posed by BPA is that organisms in the environment,
rather than being exposed to a single chemical at a time, are likely to
be exposed simultaneously to multiple chemicals. The presence of other
endocrine-active chemicals, including other estrogenic chemicals, for
example, could affect the potential for effects on environmental
organisms. It may be useful, when monitoring for BPA, to identify the
total estrogenicity of a sample along with the amount of BPA present.
Potential methodologies and protocols for use in monitoring
programs may include ASTM D7574-09 Standard Test Method for
Determination of Bisphenol A in Environmental Waters by Liquid
Chromatography/Tandem Mass Spectrometry (Ref. 62); ASTM D5730-04
Standard Guide for Site Characterization for Environmental Purposes
With Emphasis on Soil, Rock, the Vadose Zone and Ground Water (Ref.
63); EPA Method 8270D (SW-846), Semivolatile Organic Compounds by Gas
Chromatography/Mass Spectrometry (GC/MS), Revision 4 (Ref. 64); and
other methods cited and described in such publications as Barnes et al.
(2008) (Ref. 51)